10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 001-14920

 McCORMICK & COMPANY, INCORPORATED

(Exact name of registrant as specified in its charter)

Maryland	52-0408290
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

 

24 Schilling Road, Suite 1,
Hunt Valley,	MD	21031
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code    (410) 771-7301

Securities registered pursuant to Section 12(b) of the Act:

	Trading
Title of each class	Symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $0.01 per share	MKC.V	New York Stock Exchange
Common Stock Non-Voting, Par Value $0.01 per share	MKC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-Accelerated Filer	☐	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

	Shares Outstanding
	February 28, 2022
Common Stock	17,850,968
Common Stock Non-Voting	250,225,522

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION			4
	ITEM 1	FINANCIAL STATEMENTS	4
	ITEM 2	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	20
	ITEM 3	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	36
	ITEM 4	CONTROLS AND PROCEDURES	36
PART II - OTHER INFORMATION			37
	ITEM 1	LEGAL PROCEEDINGS	37
	ITEM 1a	RISK FACTORS	37
	ITEM 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	37
	ITEM 3	DEFAULTS UPON SENIOR SECURITIES	38
	ITEM 4	MINE SAFETY DISCLOSURES	38
	ITEM 5	OTHER INFORMATION	39
	ITEM 6	EXHIBITS	39

3

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

McCORMICK & COMPANY, INCORPORATED

CONDENSED CONSOLIDATED INCOME STATEMENT (UNAUDITED)

(in millions except per share amounts)

 

	Three months ended February 28,
	2022		2021
Net sales	$	1,522.4	$	1,481.5
Cost of goods sold	962.0		904.0
Gross profit	560.4		577.5
Selling, general and administrative expense	333.3		321.3
Transaction and integration expenses	0.7		18.8
Special charges	19.5		1.1
Operating income	206.9		236.3
Interest expense	33.1		33.8
Other income, net	6.2		4.6
Income from consolidated operations before income taxes	180.0		207.1
Income tax expense	34.4		58.6
Net income from consolidated operations	145.6		148.5
Income from unconsolidated operations	9.3		13.3
Net income	$	154.9	$	161.8
Earnings per share – basic	$	0.58	$	0.61
Earnings per share – diluted	$	0.57	$	0.60
Average shares outstanding – basic	267.8		267.1
Average shares outstanding – diluted	270.5		269.9
Cash dividends paid per share – voting and non-voting	$	0.37	$	0.34

See notes to condensed consolidated financial statements (unaudited).

4

McCORMICK & COMPANY, INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)

(in millions)

 

	Three months ended February 28,
	2022		2021
Net income	$	154.9	$	161.8
Net income attributable to non-controlling interest	2.5		0.8
Other comprehensive income (loss):
Unrealized components of pension and other postretirement plans	2.2		1.1
Currency translation adjustments	3.7		45.7
Change in derivative financial instruments	5.1		(1.0)
Deferred taxes	(1.0)		3.0
Total other comprehensive income	10.0		48.8
Comprehensive income	$	167.4	$	211.4

See notes to condensed consolidated financial statements (unaudited).

5

McCORMICK & COMPANY, INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEET

(in millions)

 

	February 28, 2022		November 30, 2021
	(unaudited)
ASSETS
Cash and cash equivalents	$	338.4	$	351.7
Trade accounts receivable, net of allowances	516.7		549.5
Inventories, net
Finished products	571.5		556.2
Raw materials and work-in-process	672.7		626.1
	1,244.2		1,182.3
Prepaid expenses and other current assets	139.7		112.3
Total current assets	2,239.0		2,195.8
Property, plant and equipment, net	1,135.9		1,140.3
Goodwill	5,333.4		5,335.8
Intangible assets, net	3,443.7		3,452.5
Other long-term assets	788.8		781.4
Total assets	$	12,940.8	$	12,905.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Short-term borrowings	$	636.7	$	539.1
Current portion of long-term debt	770.8		770.3
Trade accounts payable	1,072.6		1,064.2
Other accrued liabilities	596.6		850.2
Total current liabilities	3,076.7		3,223.8
Long-term debt	3,964.5		3,973.3
Deferred taxes	796.5		792.3
Other long-term liabilities	488.9		490.9
Total liabilities	8,326.6		8,480.3
Shareholders’ Equity
Common stock	542.1		530.0
Common stock non-voting	1,549.2		1,525.1
Retained earnings	2,922.4		2,782.4
Accumulated other comprehensive loss	(416.0)		(426.5)
Total McCormick shareholders' equity	4,597.7		4,411.0
Non-controlling interests	16.5		14.5
Total shareholders’ equity	4,614.2		4,425.5
Total liabilities and shareholders’ equity	$	12,940.8	$	12,905.8

See notes to condensed consolidated financial statements (unaudited).

6

McCORMICK & COMPANY, INCORPORATED

CONDENSED CONSOLIDATED CASH FLOW STATEMENT (UNAUDITED)

(in millions)

 

	Three months ended February 28,
	2022		2021
Operating activities
Net income	$	154.9	$	161.8
Adjustments to reconcile net income to net cash flow provided by operating activities:
Depreciation and amortization	49.0		48.1
Stock-based compensation	11.1		14.2
Amortization of inventory fair value adjustments associated with acquisitions	—		6.3
Income from unconsolidated operations	(9.3)		(13.3)
Changes in operating assets and liabilities (net of businesses acquired)
Trade accounts receivable	33.2		31.0
Inventories	(49.9)		(21.5)
Trade accounts payable	5.2		(73.6)
Other assets and liabilities	(185.5)		(192.2)
Dividends from unconsolidated affiliates	9.2		7.0
Net cash flow provided by (used in) operating activities	17.9		(32.2)
Investing activities
Acquisition of businesses (net of cash acquired)	—		(706.6)
Capital expenditures (including software)	(43.7)		(48.6)
Net cash flow used in investing activities	(43.7)		(755.2)
Financing activities
Short-term borrowings, net	97.3		(292.4)
Long-term debt borrowings	—		1,000.4
Payment of debt issuance costs	—		(1.1)
Long-term debt repayments	(3.5)		(1.8)
Proceeds from exercised stock options	30.3		3.6
Taxes withheld and paid on employee stock awards	(12.0)		(5.1)
Common stock acquired by purchase	(8.7)		(0.1)
Dividends paid	(99.0)		(90.8)
Net cash flow provided by financing activities	4.4		612.7
Effect of exchange rate changes on cash and cash equivalents	8.1		7.2
Decrease in cash and cash equivalents	(13.3)		(167.5)
Cash and cash equivalents at beginning of period	351.7		423.6
Cash and cash equivalents at end of period	$	338.4	$	256.1

See notes to condensed consolidated financial statements (unaudited).

7

McCORMICK & COMPANY, INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED)

(in millions)

(millions)	Common Stock Shares	Common Stock Non-Voting Shares	Common Stock Amount		Retained Earnings		Accumulated Other Comprehensive (Loss) Income		Non-controlling Interests		Total Shareholders’ Equity
Three months ended February 28, 2022
Balance, November 30, 2021	17.8	249.5	$	2,055.1	$	2,782.4	$	(426.5)	$	14.5	$	4,425.5
Net income			—		154.9		—		—		154.9
Net income attributable to non-controlling interest			—		—		—		2.5		2.5
Other comprehensive income (loss), net of tax			—		—		10.5		(0.5)		10.0
Stock-based compensation			11.1		—		—		—		11.1
Shares purchased and retired	(0.2)	—	(6.5)		(14.9)		—		—		(21.4)
Shares issued	0.9	—	31.6		—		—		—		31.6
Equal exchange	(0.7)	0.7	—		—		—		—		—
Balance, February 28, 2022	17.8	250.2	$	2,091.3	$	2,922.4	$	(416.0)	$	16.5	$	4,614.2
Three months ended February 28, 2021
Balance, November 30, 2020	18.0	248.9	$	1,981.3	$	2,415.6	$	(470.8)	$	13.9	$	3,940.0
Net income			—		161.8		—		—		161.8
Net income attributable to non-controlling interest			—		—		—		0.8		0.8
Other comprehensive income, net of tax			—		—		48.3		0.5		48.8
Stock-based compensation			14.2		—		—		—		14.2
Shares purchased and retired	(0.1)	—	(1.6)		(3.8)		—		—		(5.4)
Shares issued	0.2	—	4.5		—		—		—		4.5
Equal exchange	(0.1)	0.1	—		—		—		—		—
Balance, February 28, 2021	18.0	249.0	$	1,998.4	$	2,573.6	$	(422.5)	$	15.2	$	4,164.7

See notes to condensed consolidated financial statements (unaudited).

8

McCORMICK & COMPANY, INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1.ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States generally accepted accounting principles (U.S. GAAP) for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements contain all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position and the results of operations for the interim periods presented.

The results of consolidated operations for the three-month period ended February 28, 2022 are not necessarily indicative of the results to be expected for the full year. Historically, our net sales, net income and cash flow from operations have been lower in the first half of the fiscal year and higher in the second half. The historical increase in net sales, net income and cash flow from operations in the second half of the year has largely been due to the consumer business cycle in the U.S., where customers typically purchase more products in the fourth quarter due to the Thanksgiving and Christmas holiday seasons.

For further information, refer to the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended November 30, 2021.

Accounting Pronouncements Adopted in 2022

In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The new guidance removes certain exceptions to the general principles for income taxes and also improves consistent application of accounting by clarifying or amending existing guidance. The new standard was adopted effective December 1, 2021. There was no material impact to our consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020-04 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting that provides optional expedients for a limited period of time for accounting for contracts, hedging relationships, and other transactions affected by the London Interbank Offered Rate (LIBOR) or other reference rates expected to be discontinued. These optional expedients can be applied from March 2020 through December 31, 2022. LIBOR is used as a reference rate on our variable rate debt, including our revolving credit facility, synthetic lease, interest rate swaps, and cross currency interest rate swaps. The phase out of LIBOR reference rates will occur at different dates and began on January 1, 2022. Our adoption of this new standard occurred during the three months ended February 28, 2022, in conjunction with the first phase-out of a LIBOR reference rate. There was no material impact to our consolidated financial statements during the three months ended February 28, 2022, nor do we expect the adoption of this standard to have a material impact on our consolidated financial statements during the LIBOR transition period.

2.      SPECIAL CHARGES AND TRANSACTION AND INTEGRATION EXPENSES

Special Charges

In our consolidated income statement, we include a separate line item captioned "Special charges" in arriving at our consolidated operating income. Special charges consist of expenses, including related impairment charges, associated with certain actions undertaken to reduce fixed costs, simplify or improve processes, and improve our competitiveness and are of such significance in terms of both up-front costs and organizational/structural impact to require advance approval by our Management Committee, comprised of our senior management, including our Chairman, President and Chief Executive Officer. Upon presentation of any such proposed action (generally including details with respect to estimated costs, which typically consist principally of employee severance and related benefits, together with ancillary costs associated with the action that may include a non-cash component, such as an asset impairment, or a component which relates to inventory adjustments that are included in cost of goods sold; impacted employees or operations; expected timing; and expected savings) to the Management Committee and the Committee’s advance approval, expenses associated with the approved action are classified as special charges upon recognition and monitored on an on-going basis through completion. Certain ancillary expenses related to these actions approved by our Management Committee do not qualify for accrual upon approval but are included as special charges as incurred during the course of the actions.

We continue to evaluate changes to our organization structure to enable us to reduce fixed costs, simplify or improve processes, and improve our competitiveness.

9

The following is a summary of special charges recognized in the three months ended February 28, 2022 and 2021

(in millions):

	Three months ended February 28,
	2022		2021
Employee severance and related benefits	$	14.2	$	0.3
Other costs (1)	5.3		0.8
Total	$	19.5	$	1.1

(1) Included in other costs for 2022 is non-cash accelerated depreciation of $1.4 million.

During the three months ended February 28, 2022, we recorded $19.5 million of special charges, consisting principally of $14.9 million associated with the transition of a manufacturing facility in Europe, Middle East, and Africa (EMEA), as more fully described below, streamlining actions of $2.1 million in the Americas region, and $1.5 million in the EMEA region.

In 2022, our Management Committee approved an initiative to consolidate our manufacturing operations into a net-zero carbon condiments manufacturing and distribution center facility with state-of-the-art technology in the United Kingdom. We expect to execute these changes to our supply chain operations and improve profitability, from a combination of lower headcount and non-headcount costs, by consolidating our operations into a scalable platform while expanding our capacity. We expect the cost of the initiative to approximate $30 million—to be recognized as special charges in our consolidated income statement through 2023. Of that $30 million, we expect the costs to include employee severance and related benefits, non-cash accelerated depreciation, decommissioning and other property related lease exit costs, all directly related to the initiative. During the three months ended February 28, 2022, we recorded $12.5 million in severance and related benefits costs, $1.4 million in accelerated depreciation and $1.0 million in third party expenses and other costs.

During the three months ended February 28, 2021, we recorded $1.1 million of special charges, consisting principally of streamlining actions of $0.6 million in the EMEA region and $0.5 million in the Americas region.

In 2017, our Management Committee approved a multi-year initiative during which we expect to execute significant changes to our global processes, capabilities and operating model to provide a scalable platform for future growth. We expect this initiative to enable us to accelerate our ability to work globally and cross-functionally by aligning and simplifying processes throughout McCormick, in part building upon our current shared services foundation and expanding the end-to-end processes presently under that foundation. We expect this initiative, which we refer to as Global Enablement ("GE"), to enable this scalable platform for future growth while reducing costs, enabling faster decision making, increasing agility and creating capacity within our organization.

While we are continuing to fully develop the details of our GE operating model, we expect the cost of the GE initiative—to be recognized as special charges in our consolidated income statement over its expected multi-year course—to range from approximately $60 million to $65 million. Of that $60 million to $65 million, we estimate that approximately sixty percent will be attributable to cash payments associated with the related costs of the GE implementation and transition, including outside consulting and other costs, and approximately forty percent will be attributable to severance and related benefit payments, all directly related to this initiative. We have spent a cumulative total of $40.7 million on this initiative through February 28, 2022.

As of February 28, 2022, reserves associated with special charges, which are expected to be paid during the next twelve months, are included in trade accounts payable and other accrued liabilities in our consolidated balance sheet.

The following is a breakdown by business segment of special charges for the three months ended February 28, 2022 and 2021 (in millions):

	Three months ended February 28,
	2022		2021
Consumer segment	$	3.6	$	0.8
Flavor solutions segment	15.9		0.3
Total special charges	$	19.5	$	1.1

Transaction and Integration Expenses

The following are the transaction and integration expenses recognized during the three months ended February 28, 2022 and 2021 relating to the acquisitions of Cholula Hot Sauce ("Cholula") and FONA International, LLC ("FONA") (in millions):

10

	2022		2021
Transaction-related expenses included in cost of goods sold	$	—	$	6.3
Other transaction expenses	—		13.8
Integration expenses	0.7		5.0
Total transaction and integration expenses	$	0.7	$	25.1

We expect transaction and integration expenses related to our acquisition of FONA to total approximately $3 million in 2022.

3.    FINANCIAL INSTRUMENTS

We use derivative financial instruments to enhance our ability to manage risk, including foreign currency, net investment and interest rate exposures, which exist as part of our ongoing business operations. We do not enter into contracts for trading purposes, nor are we a party to any leveraged derivative instrument, and all derivatives are designated as hedges. For the three months ended February 28, 2022 and 2021, hedge ineffectiveness was not material. We are not a party to master netting arrangements, and we do not offset the fair value of derivative contracts with the same counterparty in our financial statement disclosures. The use of derivative financial instruments is monitored through regular communication with senior management and the use of written guidelines.

Foreign currency exchange risk. We are potentially exposed to foreign currency fluctuations affecting net investments in subsidiaries, transactions (both third-party and intercompany) and earnings denominated in foreign currencies. We assess foreign currency risk based on transactional cash flows and translational volatility and may enter into forward contract and currency swaps with highly-rated financial institutions to reduce fluctuations in the long or short currency positions. Forward contracts are generally less than 18 months duration. Currency swap agreements are established in conjunction with the terms of the underlying debt issues.

At February 28, 2022, we had foreign currency exchange contracts to purchase or sell $636.5 million of foreign currencies as compared to $583.6 million at November 30, 2021. All of these contracts were designated as hedges of anticipated purchases denominated in a foreign currency or hedges of foreign currency denominated assets or liabilities. All foreign currency exchange contracts outstanding at February 28, 2022 have durations of less than 18 months, including $242.1 million of notional contracts that have durations of less than one month and are used to hedge short-term cash flow funding.

Contracts which are designated as hedges of anticipated purchases denominated in a foreign currency (generally purchases of raw materials in U.S. dollars by operating units outside the U.S.) are considered cash flow hedges. The gains and losses on these contracts are deferred in accumulated other comprehensive loss until the hedged item is recognized in cost of goods sold, at which time the net amount deferred in accumulated other comprehensive loss is also recognized in cost of goods sold. Gains and losses from contracts that are designated as hedges of assets, liabilities or firm commitments are recognized through income, offsetting the change in fair value of the hedged item.

We also enter into fair value foreign currency exchange contracts to manage both exposure to currency fluctuations in certain intercompany loans between subsidiaries as well as currency exposure to third-party non-functional currency assets or liabilities. At February 28, 2022, the notional value of these contracts was $413.4 million. Any gains or losses recorded based on both the change in fair value of these contracts and the change in the currency component of the underlying loans are recognized in our consolidated income statement as Other income, net.

We also utilize cross currency interest rate swap contracts that are designated as net investment hedges. Any gains or losses on net investment hedges are included in foreign currency translation adjustments in accumulated other comprehensive loss.

Interest rate risk. We finance a portion of our operations with both fixed and variable rate debt instruments, principally commercial paper, notes and bank loans. We utilize interest rate swap agreements to minimize worldwide financing costs and to achieve a desired mix of variable and fixed rate debt.

11

The following table discloses the notional amount and fair values of derivative instruments on our balance sheet (in millions):

As of February 28, 2022	Asset Derivatives					Liability Derivatives
	Balance sheet location	Notional amount		Fair value		Balance sheet location	Notional amount		Fair value
Interest rate contracts	Other current assets / Other long-term assets	$	600.0	$	14.6	Other accrued liabilities	$	—	$	—
Foreign exchange contracts	Other current assets	444.5		7.7		Other accrued liabilities	192.0		2.8
Cross currency contracts	Other current assets / Other long-term assets	495.3		10.9		Other long-term liabilities	505.7		14.1
Total				$	33.2				$	16.9
As of November 30, 2021	Asset Derivatives					Liability Derivatives
	Balance sheet location	Notional amount		Fair value		Balance sheet location	Notional amount		Fair value
Interest rate contracts	Other current assets / Other long-term assets	$	350.0	$	23.1	Other accrued liabilities	$	—	$	—
Foreign exchange contracts	Other current assets	380.8		8.3		Other accrued liabilities	202.8		2.8
Cross currency contracts	Other current assets / Other long-term assets	251.0		4.4		Other long-term liabilities	257.5		8.0
Total				$	35.8				$	10.8

During the first quarter of 2022, we entered into $250 million notional value interest rate swap contracts where we receive interest at 2.50% and pay a variable rate of interest based on USD SOFR plus 0.745%, which expire in April 2030, and are designated as fair value hedges of the changes in fair value of $250 million of the $500 million 2.50% term notes due in 2030.The fair value of these interest rate swap contracts is offset by a corresponding increase or decrease in the value of the hedged debt. Also during the first quarter of 2022, we entered into cross currency interest rate swap contracts of (i) $250 million notional value to receive $250 million at USD SOFR plus 0.745% and pay £184.1 million at GBP SONIA plus 0.5740% and (ii) £184.1 million notional value to receive £184.1 million at GBP SONIA plus 0.574% and pay €219.2 million at Euro ESTR plus 0.667%, both of which expire in April 2030. In conjunction with the phase-out of LIBOR, during the first quarter of 2022 we amended our previously existing cross currency swaps which expire in August 2027 such that, effective February 15, 2022, we now pay and receive at GBP SONIA plus 0.859% (previously GBP LIBOR plus 0.740%).

12

The following tables disclose the impact of derivative instruments on our other comprehensive income (OCI), accumulated other comprehensive loss (AOCI) and our consolidated income statement for the three-months ended February 28, 2022 and 2021 (in millions):

 

Fair Value Hedges
Three months ended February 28,
Derivative	Income statement location	Income (expense)
		2022		2021
Interest rate contracts	Interest expense	$	2.2	$	2.0

	Income statement location	Gain (loss) recognized in income					Income statement location	Gain (loss) recognized in income
Derivative		2022		2021		Hedged item		2022		2021
Foreign exchange contracts	Other income, net	$	(0.4)	$	(2.1)	Intercompany loans	Other income, net	$	0.4	$	2.4

The gains (losses) recognized on fair value hedges relating to currency exposure on third-party non-functional currency assets or liabilities were not material during the three-months ended February 28, 2022 and 2021.

Cash Flow Hedges
Three months ended February 28,
Derivative	Gain (loss) recognized in OCI				Income statement location	Gain (loss) reclassified from AOCI
	2022		2021			2022		2021
Interest rate contracts	$	—	$	0.3	Interest expense	$	0.1	$	0.1
Foreign exchange contracts	2.9		(1.6)		Cost of goods sold	(0.2)		0.3
Total	$	2.9	$	(1.3)		$	(0.1)	$	0.4

For all cash flow and settled interest rate fair value hedge derivatives, the net amount of accumulated other comprehensive loss expected to be reclassified in the next 12 months is $2.8 million as an increase to earnings.

Net Investment Hedges
Three months ended February 28,
Derivative	Gain (loss) recognized in OCI				Income statement location	Gain (loss) excluded from the assessment of hedge effectiveness
	2022		2021			2022		2021
Cross currency contracts	$	0.7	$	(2.0)	Interest expense	$	0.5	$	0.4

For all net investment hedges, no amounts have been reclassified out of accumulated other comprehensive loss. The amounts noted in the tables above for OCI do not include any adjustments for the impact of deferred income taxes.

13

4.    FAIR VALUE MEASUREMENTS

Fair value can be measured using valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

•Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

•Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

•Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

At February 28, 2022 and November 30, 2021, we had no financial assets or liabilities that were subject to a level 3 fair value measurement. Our population of financial assets and liabilities subject to fair value measurements on a recurring basis are as follows (in millions):

			February 28, 2022
	Fair Value		Level 1		Level 2
Assets
Cash and cash equivalents	$	338.4	$	338.4	$	—
Insurance contracts	126.8		—		126.8
Bonds and other long-term investments	4.1		4.1		—
Interest rate derivatives	14.6		—		14.6
Foreign currency derivatives	7.7		—		7.7
Cross currency contracts	10.9		—		10.9
Total	$	502.5	$	342.5	$	160.0
Liabilities
Foreign currency derivatives	$	2.8	$	—	$	2.8
Cross currency contracts	14.1		—		14.1
Total	$	16.9	$	—	$	16.9

 

			November 30, 2021
	Fair Value		Level 1		Level 2
Assets
Cash and cash equivalents	$	351.7	$	351.7	$	—
Insurance contracts	132.2		—		132.2
Bonds and other long-term investments	5.1		5.1		—
Interest rate derivatives	23.1		—		23.1
Foreign currency derivatives	8.3		—		8.3
Cross currency contracts	4.4		—		4.4
Total	$	524.8	$	356.8	$	168.0
Liabilities
Foreign currency derivatives	$	2.8	$	—	$	2.8
Cross currency contracts	8.0		—		8.0
Total	$	10.8	$	—	$	10.8

At February 28, 2022 and November 30, 2021, the carrying amounts of interest rate derivatives, foreign currency derivatives, cross currency contracts, insurance contracts, and bond and other long-term investments are equal to their respective fair values. Because of their short-term nature, the amounts reported in the balance sheet for cash and cash equivalents, receivables, short-

14

term borrowings and trade accounts payable approximate fair value. Investments in affiliates are not readily marketable, and it is not practicable to estimate their fair value.

Insurance contracts, bonds, and other long-term investments are comprised of fixed income and equity securities held for certain non-qualified U.S. employee benefit plans and are stated at fair value on the balance sheet. The fair values of insurance contracts are based upon the underlying values of the securities in which they are invested and are from quoted market prices from various stock and bond exchanges for similar type assets. The fair values of bonds and other long-term investments are based on quoted market prices from various stock and bond exchanges. The fair values for interest rate derivatives, foreign currency derivatives, and cross currency contracts are based on values for similar instruments using models with market-based inputs.

The following table sets forth the carrying amounts and fair values of our long-term debt including the current portion thereof (in millions):

	February 28, 2022		November 30, 2021
Carrying amount	$	4,735.3	$	4,743.6
Level 1 valuation techniques	$	4,571.8	$	4,722.3
Level 2 valuation techniques	196.3		199.2
Total fair value	$	4,768.1	$	4,921.5

The fair value for Level 2 long-term debt is determined by using quoted prices for similar debt instruments.

5.     EMPLOYEE BENEFIT AND RETIREMENT PLANS    

We sponsor defined benefit pension plans in the U.S. and certain foreign locations. In addition, we sponsor defined contribution plans in the U.S. We also contribute to defined contribution plans in locations outside the U.S., including government-sponsored retirement plans. We also currently provide postretirement medical and life insurance benefits to certain U.S. employees and retirees. We previously froze the accrual of future benefits under certain defined benefit pension plans in the U.S. and certain foreign locations. Although our defined benefit plans in the U.S., United Kingdom and Canada have generally been frozen, employees who are participants in the plans retained benefits accumulated up to the date of the freeze, based on credited service and eligible earnings, in accordance with the terms of the plans.

The following table presents the components of our pension (income) and other postretirement benefits expense for the three months ended February 28, 2022 and 2021 (in millions):

	United States pension				International pension				Other postretirement benefits
	2022		2021		2022		2021		2022		2021
Service cost	$	0.9	$	0.9	$	0.2	$	0.3	$	0.4	$	0.5
Interest costs	6.6		6.5		1.8		1.7		0.4		0.4
Expected return on plan assets	(10.7)		(10.3)		(3.2)		(3.5)		—		—
Amortization of prior service costs	0.1		0.1		—		—		(0.1)		(0.1)
Amortization of net actuarial losses	2.2		2.8		0.4		0.6		—		—
Total (income) expense	$	(0.9)	$	—	$	(0.8)	$	(0.9)	$	0.7	$	0.8

During the three months ended February 28, 2022 and 2021, we contributed $2.0 million and $2.3 million, respectively, to our pension plans. Total contributions to our pension plans in fiscal year 2021 were $15.0 million.

All of the amounts in the tables above for pension (income) and other postretirement benefits expense, other than service cost, were included in other income, net within our consolidated income statements. The net aggregate amount of pension and other postretirement benefits (income), excluding service cost components, was $(2.5) million and $(1.8) million for the three months ended February 28, 2022 and 2021, respectively.

6.    STOCK-BASED COMPENSATION

We have four types of stock-based compensation awards: restricted stock units ("RSUs"), stock options, company stock

15

awarded as part of our long-term performance plan ("LTPP") and price-vested stock options. The following table sets forth the stock-based compensation expense recorded in selling, general and administrative ("SG&A") expense (in millions):

	Three months ended February 28,
	2022		2021
Stock-based compensation expense	$	11.1	$	14.2

Our 2022 annual grant of stock options and RSUs is expected to occur in the second quarter, similar to the 2021 annual grant.

The following is a summary of our stock option activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in millions)	Number of Shares	Weighted- Average Exercise Price		Number of Shares	Weighted- Average Exercise Price
Outstanding at beginning of period	5.0	$	59.71	4.5	$	53.56
Exercised	(0.6)	45.25		(0.1)	39.30
Outstanding at end of the period	4.4	$	61.72	4.4	$	53.62
Exercisable at end of the period	3.0	$	53.17	3.2	$	47.95

As of February 28, 2022, the intrinsic value (the difference between the exercise price and the market price) for all options outstanding was $145.5 million and for options currently exercisable was $128.0 million. The total intrinsic value of all options exercised during the three months ended February 28, 2022 and 2021 was $32.6 million and $2.2 million, respectively.

The following is a summary of our RSU activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	563	$	69.52	714	$	61.74
Granted	6	92.47		10	91.85
Vested	(24)	54.02		(10)	47.70
Forfeited	(8)	78.51		(6)	65.74
Outstanding at end of period	537	$	70.31	708	$	62.34

16

The following is a summary of our price-vested stock options activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	2,193	$	9.40	2,482	$	9.40
Granted	—	—		15	9.66
Forfeited	(27)	9.40		(13)	9.40
Outstanding at end of period	2,166	$	9.40	2,484	$	9.40

The following is a summary of our LTPP activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	497	$	83.74	382	$	71.20
Granted	151	95.00		141	98.30
Vested	(251)	75.26		(121)	50.95
Forfeited	(2)	96.03		(5)	82.59
Outstanding at end of period	395	$	93.42	397	$	86.89

7.    INCOME TAXES

Income tax expense for the three months ended February 28, 2022 included $10.3 million of net discrete tax benefits consisting principally of the following: (i) $7.6 million of excess tax benefits associated with stock-based compensation, and (ii) $2.5 million of tax benefits related to the revaluation of deferred taxes resulting from enacted legislation.

Income tax expense for the three months ended February 28, 2021 included $5.3 million of net discrete tax expense consisting principally of the following: (i) $11.4 million of deferred state tax expense directly related to our December 2020 acquisition of FONA, (ii) $4.5 million of tax benefits associated with the release of a valuation allowance due to a change in judgment about realizability of deferred tax assets, and (iii) $1.2 million of tax benefits from the reversal of certain reserves for unrecognized tax benefits associated with the resolution of tax uncertainties.

Other than additions for current year tax positions, there were no significant changes to unrecognized tax benefits during the three months ended February 28, 2022.

As of February 28, 2022, we believe the reasonably possible total amount of unrecognized tax benefits that could increase or decrease in the next 12 months as a result of various statute expirations, audit closures, and/or tax settlements would not be material to our consolidated financial statements.

8.    CAPITAL STOCK AND EARNINGS PER SHARE

The following table sets forth the reconciliation of average shares outstanding (in millions):

	Three months ended February 28,
	2022	2021
Average shares outstanding – basic	267.8	267.1
Effect of dilutive securities:
Stock options/RSUs/LTPP	2.7	2.8
Average shares outstanding – diluted	270.5	269.9

17

The following table sets forth the stock options and RSUs that were not considered in our earnings per share calculation since they were anti-dilutive (in millions):

	Three months ended February 28,
	2022	2021
Anti-dilutive securities	0.2	—

The following table sets forth common stock activity (in millions):

	Three months ended February 28,
	2022	2021
Shares issued under stock options, RSUs, LTPP and employee stock purchase plans	0.9	0.2
Shares repurchased under the stock repurchase program and shares withheld for taxes under stock options, RSUs, and LTPP	0.2	0.1

As of February 28, 2022, $567.4 million remained of the $600 million share repurchase program authorization approved by our Board of Directors in November 2019.

9.    ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table sets forth the components of accumulated other comprehensive loss, net of tax, where applicable (in millions):

	February 28, 2022		November 30, 2021
Foreign currency translation adjustment (1)	$	(228.7)	$	(233.3)
Unrealized gain (loss) on foreign currency exchange contracts	5.1		0.6
Unamortized value of settled interest rate swaps	(0.4)		(0.2)
Pension and other postretirement costs	(192.0)		(193.6)
Accumulated other comprehensive loss	$	(416.0)	$	(426.5)

(1)During the three months ended February 28, 2022, the foreign currency translation adjustment of accumulated other comprehensive loss decreased on a net basis by $4.6 million, including the impact of a $0.7 million increase associated with net investment hedges. These net investment hedges are more fully described in note 3.

The following table sets forth the amounts reclassified from accumulated other comprehensive income (loss) and into consolidated net income (in millions):

	Three months ended				Affected Line Items in the Condensed Consolidated Income Statement
	February 28, 2022		February 28, 2021
(Gains)/losses on cash flow hedges:
Interest rate derivatives	$	(0.1)	$	(0.1)	Interest expense
Foreign exchange contracts	0.2		(0.3)		Cost of goods sold
Total before tax	0.1		(0.4)
Tax effect	—		0.1		Income tax expense
Net, after tax	$	0.1	$	(0.3)
Amortization of pension and postretirement benefit adjustments:
Amortization of net actuarial losses (1)	$	2.6	$	3.4	Other income, net
Total before tax	2.6		3.4
Tax effect	(0.6)		(0.8)		Income tax expense
Net, after tax	$	2.0	$	2.6

18

(1)This accumulated other comprehensive income (loss) component is included in the computation of total pension (income) and other postretirement benefits expense (refer to note 5 for additional details). Amortization of net actuarial losses includes settlement losses.

10.    BUSINESS SEGMENTS

We operate in two business segments: consumer and flavor solutions. The consumer and flavor solutions segments manufacture, market and distribute spices, herbs, seasoning mixes, condiments and other flavorful products throughout the world. Our consumer segment sells to retail channels, including grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce under the “McCormick” brand and a variety of brands around the world, including “French’s”, “Frank’s RedHot”, “OLD BAY”, “Lawry’s”, “Zatarain’s”, “Simply Asia”, “Thai Kitchen”, “Ducros”, “Vahine”, “Cholula”, “Schwartz”, “Club House”, “Kamis”, “DaQiao”, “La Drogheria”, “Stubb's”, and “Gourmet Garden”. Our flavor solutions segment sells to food manufacturers and the foodservice industry both directly and indirectly through distributors, with the exception of our businesses in China and India, where foodservice sales are managed by and reported in our consumer segment.

In each of our segments, we produce and sell many individual products which are similar in composition and nature. With their primary attribute being flavor, we regard the products within each of our segments to be fairly homogenous. It is impracticable to segregate and identify sales and profits for each of these individual product lines.

We measure segment performance based on operating income excluding special charges, as this activity is managed separately from the business segments. We also exclude transaction and integration expenses related to our acquisitions, including the recent acquisitions of Cholula and FONA from our measure of segment performance as these expenses are similarly managed separately from the business segments. These transaction and integration expenses excluded from our segment performance measure include the amortization of the acquisition-date fair value adjustment of inventories that is included in cost of goods sold, costs directly associated with that acquisition and costs associated with integrating the businesses.

Although the segments are managed separately due to their distinct distribution channels and marketing strategies, manufacturing and warehousing are often integrated to maximize cost efficiencies. We do not segregate jointly utilized assets by individual segment for internal reporting, evaluating performance or allocating capital. Because of manufacturing integration for certain products within the segments, products are not sold from one segment to another but rather inventory is transferred at cost. Intersegment sales are not material.

 

	Consumer		Flavor Solutions		Total
			(in millions)
Three months ended February 28, 2022
Net sales	$	926.1	$	596.3	$	1,522.4
Operating income excluding special charges and transaction and integration expenses	167.0		60.1		227.1
Income from unconsolidated operations	8.4		0.9		9.3
Three months ended February 28, 2021
Net sales	$	946.8	$	534.7	$	1,481.5
Operating income excluding special charges and transaction and integration expenses	189.9		72.6		262.5
Income from unconsolidated operations	10.8		2.5		13.3

19

A reconciliation of operating income excluding special charges and transaction and integration expenses, to operating income is as follows (in millions):

	Consumer		Flavor Solutions		Total
Three months ended February 28, 2022
Operating income excluding special charges and transaction and integration expenses	$	167.0	$	60.1	$	227.1
Less: Special charges	3.6		15.9		19.5
Less: Transaction and integration expenses	—		0.7		0.7
Operating income	$	163.4	$	43.5	$	206.9
Three months ended February 28, 2021
Operating income excluding special charges and transaction and integration expenses	$	189.9	$	72.6	$	262.5
Less: Special charges	0.8		0.3		1.1
Less: Transaction-related expenses included in cost of goods sold	4.0		2.3		6.3
Less: Other transaction and integration expenses	4.2		14.6		18.8
Operating income	$	180.9	$	55.4	$	236.3

The following table sets forth our net sales, by geographic area, for the three months ended February 28, 2022 and 2021 (in millions):

	Americas		EMEA		Asia/Pacific		Total
Three months ended February 28, 2022	$	1,022.5	$	290.5	$	209.4	$	1,522.4
Three months ended February 28, 2021	964.8		302.4		214.3		1,481.5

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

OVERVIEW

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to help the reader understand McCormick & Company, Incorporated, our operations, and our present business environment. MD&A is provided as a supplement to, and should be read in conjunction with, our financial statements and the accompanying notes thereto, included in Item 1 of this report. We use certain non-GAAP information – more fully described below under the caption Non-GAAP Financial Measures – that we believe is important for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of our ongoing operations and analyze our business performance and trends. Unless otherwise noted, the dollar and share information in the charts and tables in MD&A are in millions, except per share data.

Business profile

McCormick is a global leader in flavor. We manufacture, market and distribute spices, seasoning mixes, condiments and other flavorful products to the entire food industry – retailers, food manufacturers and the foodservice business. In fiscal year 2021, approximately 40% of our sales were outside of the U.S. We also are partners in a number of joint ventures that are involved in the manufacture and sale of flavorful products, the most significant of which is McCormick de Mexico. We manage our business in two business segments, consumer and flavor solutions.

Recent Events

Recent events impacting our business include COVID-19, the inflationary cost environment and disruption in our supply chain, and Russia’s invasion of Ukraine, each of which are further discussed below. As more fully described below, we expect each of these factors will impact our fiscal 2022 performance. We anticipate that fiscal 2022 will continue to be a dynamic macroeconomic environment. While we expect the impacts of COVID-19 on our business to moderate, there still remains uncertainty around the pandemic, its effect on labor or other macroeconomic factors, the severity and duration of the pandemic, the continued availability and effectiveness of vaccines and actions taken by government authorities, including restrictions, laws or regulations, and other third parties in response to the pandemic. We expect elevated levels of cost inflation to persist throughout 2022. We anticipate that these headwinds will be partially mitigated by pricing actions in response to inflation, supply chain productivity improvements and cost savings initiatives. Also, the invasion of Ukraine by Russia and the sanctions

20

imposed in response to this conflict have increased global economic and political uncertainty. While the impact of these factors remains uncertain, we will continue to evaluate the extent to which these factors will impact our business, financial condition, or results of operations. These and other uncertainties with respect to these recent events could result in changes to our current expectations. The potential effects of these recent events also could impact us in a number of other ways including, but not limited to, variations in the level of our profitability, laws and regulations affecting our business, fluctuations in foreign currency markets, the availability of future borrowings, the cost of borrowings, valuation of our pension assets and obligations, credit risks of our customers and counterparties, and potential impairment of the carrying value of goodwill or other indefinite-lived intangible assets.

COVID-19: As a result of the COVID-19 pandemic, uncertainty with respect to its economic effects has impacted not only our operating results but also the global economy. The extent and nature of government actions varied during the quarters ended February 28, 2022 and 2021 based upon the then-current extent and severity of the COVID-19 pandemic within their respective countries and localities.

We continue to actively monitor the impact of COVID-19 on all aspects of our business. The effects of COVID-19 on consumer behavior have impacted the relative balance of at-home versus away-from-home food demand. While we continue to see strong levels of at-home consumption compared to pre-pandemic levels, the favorable impact of increased at-home meal preparation was less significant in the three months ended February 28, 2022 as compared to the comparable period of 2021. This change in consumer behavior was due in part to a decrease in the prevalence and scale of restrictive measures in place to reduce the spread of COVID-19 in the 2022 period as compared to 2021. Conversely, we continue to see improvements in away-from-home demand associated with the COVID-19 recovery. During the three months ended February 28, 2022 our flavor solutions segment sales improved as away-from-home consumption increased as compared to the corresponding quarter in 2021, in part, due to the continued easing of restrictive COVID-19 mitigation measures that were in place during the first quarter of 2021.

Inflationary Cost Environment and Supply Chain Disruption – During fiscal 2021, we experienced inflationary cost increases in our commodities, packaging materials and transportation costs. These inflationary cost increases have continued in 2022, but we expect they will be partially mitigated by pricing actions implemented in the fourth quarter of fiscal 2021, those that we plan to implement in fiscal 2022 and by our Comprehensive Continuous Improvement (CCI) program-led cost savings. During fiscal 2021, we also experienced additional pressure in our supply chain due to strained transportation capacity, as well as due to labor shortages and absenteeism associated with COVID-19, together with the impact of the continued elevated demand. In response to these supply chain pressures, we have taken actions to build capacity as well as increase our supply chain related resources. We expect these pressures to continue throughout 2022.

Russia’s Invasion of Ukraine: The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. As we announced on March 11, 2022, we suspended our business operations in Russia. Our operations in Ukraine have been paused to focus on the safety of our employees. While neither Russia nor Ukraine constitutes a material portion of our business, a significant escalation or expansion of economic disruption or the conflict's current scope could disrupt our supply chain, broaden inflationary costs, and have a material adverse effect on our results of operations.

2022 Outlook

In 2022, we expect to grow net sales over the 2021 level by 3% to 5%, which includes an estimated 1% unfavorable impact from currency rates, or 4% to 6% on a constant currency basis (that is, excluding the impact of foreign currency exchange as more fully described under the caption, Non-GAAP Financial Measures). That anticipated 2022 sales growth includes the impact of pricing actions, including those taken in 2021, to partially offset cost increases. We expect the impact of pricing to be a significant driver of our sales growth. We expect volume and product mix to be impacted by pricing elasticities, although at a lower level than we have experienced historically. We also anticipate that our volume and product mix will be negatively impacted by the exit of a lower margin product line in late 2021.

We expect our 2022 gross profit margin to range from an increase of 20 basis points to a decline of 30 basis points from our gross profit margin of 39.5% in 2021. The projected 2022 change in gross profit margin is principally due to the net effect of (i) a mid-to-high-teen percentage impact of inflation in 2022 compared to 2021, (ii) the favorable impact of pricing actions in response to increased commodity, packaging materials and transportation costs, (iii) anticipated unfavorable sales mix in 2022 between our consumer and flavor solutions segments as compared to 2021, (iv) the favorable impact of anticipated CCI cost savings, and (v) the absence of $11.0 million of transaction and integration expenses and special charges reflected in cost of goods sold in 2021. We expect our 2022 gross profit margin, excluding the $11.0 million of transaction and integration expenses and special charges in 2021, to range from comparable to a decline of 50 basis points from our 2021 adjusted gross profit margin of 39.7%.

21

In 2022, we expect an increase in operating income of 13% to 15%, which includes an estimated 1% unfavorable impact from currency rates, over the 2021 level. Our CCI-led cost savings target in 2022 is approximately $85 million. We anticipate integration expenses related to the FONA acquisition of approximately $3 million to unfavorably impact operating income in 2022, as compared to $35.3 million of transaction and integration expenses in 2021. We also expect approximately $30 million of special charges in 2022 that relate to previously announced organization and streamlining actions; in 2021, special charges were $51.1 million. Excluding special charges and transaction and integration expenses, we expect 2022’s adjusted operating income to increase by 7% to 9%, which includes an estimated 1% unfavorable impact from currency rates, or to increase by 8% to 10% on a constant currency basis over the 2021 level.

Our underlying effective tax rate is projected to be higher in 2022 than in 2021. We estimate that our 2022 effective tax rate, including the net favorable impact of anticipated discrete tax items, will be 22% to 23% as compared to 21.5% in 2021. Excluding projected taxes associated with special charges and transaction and integration expenses, we estimate that our adjusted effective tax rate will be 22% to 23% in 2022, as compared to an adjusted effective tax rate of 20.1% in 2021.

Diluted earnings per share was $2.80 in 2021. Diluted earnings per share for 2022 is projected to range from $3.07 to $3.12. Excluding the per share impact of (i) special charges of $0.16; (ii) transaction and integration expenses, including the unfavorable impact of a discrete tax item of $0.04 related to our acquisition of FONA, of $0.14; and (iii) the gain realized upon our sale of an unconsolidated operation of $0.05, adjusted diluted earnings per share was $3.05 in 2021. Adjusted diluted earnings per share, excluding an estimated per share impact from special charges of $0.09 and from integration expenses of $0.01, is projected to range from $3.17 to $3.22 in 2022. We expect adjusted diluted earnings per share to grow by 4% to 6%, which includes a 1% unfavorable impact from currency rates, or to grow by 5% to 7% on a constant currency basis over adjusted diluted earnings per share of $3.05 in 2021.

RESULTS OF OPERATIONS – COMPANY

	Three months ended
	February 28, 2022			February 28, 2021
Net sales	$	1,522.4		$	1,481.5
Percent increase	2.8		%	22.2		%
Components of percent growth in net sales – increase (decrease):
Volume and product mix	(1.5)		%	15.2		%
Pricing actions	4.8		%	0.8		%
Acquisitions	0.7		%	4.0		%
Foreign exchange	(1.2)		%	2.2		%
Gross profit	$	560.4		$	577.5
Gross profit margin	36.8		%	39.0		%

Sales for the first quarter of 2022 increased by 2.8% from the prior year level and by 4.0% on a constant currency basis (that is, excluding the impact of foreign currency exchange as more fully described under the caption, Non-GAAP Financial Measures). Unfavorable volume and product mix decreased sales by 1.5%. That decrease was driven by our consumer segment as compared to the first quarter of 2021 which experienced a 35.4% increase in sales, including a 28.6% increase from favorable volume and product mix, from the 2020 level. The decrease in consumer segment sales was partially offset by higher sales of our flavor solutions segment across all regions, as demand was elevated as compared to the corresponding period in 2021 when away-from-home sales were more impacted by measures imposed to mitigate the spread of COVID-19. Pricing actions, taken in response to the inflationary cost environment, increased sales by 4.8%. The incremental impact of the FONA acquisition added 0.7% to sales in the first quarter of 2022. Sales were also impacted by unfavorable foreign currency rates that decreased net sales by 1.2% in the first quarter of 2022 compared to the year-ago quarter and is excluded from our measure of sales growth of 4.0% on a constant currency basis.

Gross profit for the first quarter of 2022 decreased by $17.1 million, or 3.0%, from the comparable period in 2021. Our gross profit margin for the three months ended February 28, 2022 was 36.8%, a decrease of 220 basis points from the comparable period in 2021. The decrease in gross profit margin in the quarter ended February 28, 2022 was driven by the margin dilutive impact of pricing actions taken in response to the inflationary cost environment, increased commodity, packaging materials and transportation costs, higher conversion costs and a less favorable mix in sales between our consumer and flavor solutions segments, each as compared to the 2021 period. These unfavorable impacts were partially offset by cost savings led by our

22

Comprehensive Continuous Improvement ("CCI") program as well as a reduction in COVID-19 related costs. In addition, our gross profit for the three months ended February 28 2021 was burdened by $6.3 million of transaction expense, representing the amortization of the fair value adjustment to the acquired inventories of Cholula and FONA upon our sale of those acquired inventories in the first quarter of fiscal 2021. Excluding those transaction and integration expenses, adjusted gross profit margin declined 260 basis points to 36.8% from 39.4% in 2021.

	Three months ended
	February 28, 2022			February 28, 2021
Selling, general & administrative expense (SG&A)	$	333.3		$	321.3
Percent of net sales	21.9		%	21.7		%

SG&A increased by $12.0 million in the first quarter of 2022 compared to the 2021 level, driven by SG&A associated with the acquired FONA business, increased distribution costs, and higher investment associated with the implementation of our global enterprise resource planning (ERP) platform, all as compared to the 2021 period. SG&A as a percentage of net sales increased by 20 basis points from the prior year level, due primarily to the net impact of the previously mentioned factors.

	Three months ended
	February 28, 2022		February 28, 2021
Total special charges	$	19.5	$	1.1

During the three months ended February 28, 2022, we recorded $19.5 million of special charges, consisting principally of $14.9 million associated with the transition of a manufacturing facility in Europe, Middle East, and Africa (EMEA), streamlining actions of $2.1 million in the Americas region, and $1.5 million in the EMEA region. During the three months ended February 28, 2021, we recorded $1.1 million of special charges, consisting principally of streamlining actions of $0.6 million in the EMEA region and $0.5 million in the Americas region. Details with respect to the composition of special charges are included in note 2 of the notes to the accompanying financial statements.

	Three months ended
	February 28, 2022		February 28, 2021
Transaction expenses included in cost of goods sold	$	—	$	6.3
Other transaction and integration expenses	0.7		18.8
Total transaction and integration expenses	$	0.7	$	25.1

During the three months ended February 28, 2022, we recorded $0.7 million of integration expenses related to our acquisition of FONA, as compared to $25.1 million of transaction and integration expenses in the 2021 period related to our acquisitions of Cholula and FONA. The 2021 costs consisted of (i) $6.3 million of amortization of the acquisition-date fair value adjustment of inventories that is included in cost of goods sold, (ii) $13.8 million of other transaction costs primarily related to outside advisory, service and consulting costs, and (iii) $5.0 million of integration expenses.

	Three months ended
	February 28, 2022		February 28, 2021
Interest expense	$	33.1	$	33.8
Other income, net	6.2		4.6

Interest expense decreased by $0.7 million in the three months ended February 28, 2022, as compared to the prior year period. Other income, net for the three months ended February 28, 2022 increased by $1.6 million, as compared to the prior year period, driven by higher interest income.

	Three months ended
	February 28, 2022			February 28, 2021
Income from consolidated operations before income taxes	$	180.0		$	207.1
Income tax expense	34.4			58.6
Effective tax rate	19.1		%	28.3		%

The provision for income taxes is based on the estimate of the annual effective tax rate adjusted to reflect the tax impact of items discrete to the fiscal period. We record tax expense or tax benefits that do not relate to ordinary income in the current fiscal year discretely in the period in which such items occur pursuant to the requirements of U.S. GAAP. Examples of such

23

types of discrete items not related to ordinary income of the current fiscal year include, but are not limited to, excess tax benefits associated with stock-based compensation, changes in estimates of the outcome of tax matters related to prior years, including reversals of reserves upon the lapsing of statutes of limitations, provision-to-return adjustments, the settlement of tax audits, changes in enacted tax rates, changes in the assessment of deferred tax valuation allowances, acquisition related deferred tax adjustments and the tax effects of certain intra-entity asset transfers (other than inventory).

Income tax expense for the three months ended February 28, 2022 included $10.3 million of net discrete tax benefits consisting primarily of $7.6 million of excess tax benefits associated with stock-based compensation and $2.5 million of tax benefits related to the revaluation of deferred taxes resulting from legislation enacted during the period.

Income taxes for the three months ended February 28, 2021 included $5.3 million of net discrete tax expense consisting

principally of the following: (i) $11.4 million of deferred state tax expense directly related to our December 2020 acquisition of

FONA, partially offset by (ii) $4.5 million of tax benefits associated with the release of a valuation allowance due to a change

in judgment about realizability of deferred tax assets and (iii) $1.2 million of tax benefits from the reversal of certain reserves

for unrecognized tax benefits associated with the resolution of tax uncertainties.

	Three months ended
	February 28, 2022		February 28, 2021
Income from unconsolidated operations	$	9.3	$	13.3

Income from unconsolidated operations, which is presented net of the elimination of earnings attributable to non-controlling interests, decreased by $4.0 million for the three months ended February 28, 2022, as compared to the year ago period. The decrease was driven by lower earnings of our largest joint venture, McCormick de Mexico, as well as the impact of eliminating a higher level of earnings of our non-controlling interests, both as compared to the 2021 periods.

The following table outlines the major components of the change in diluted earnings per share from 2021 to 2022:

	Three months ended February 28,
2021 Earnings per share – diluted	$	0.60
Impact of change in operating income	(0.10)
Increase in special charges, net of taxes	(0.05)
Decrease in transaction and integration expenses, including impact of net discrete tax item related to FONA acquisition	0.11
Decrease in income from unconsolidated operations	(0.01)
Impact of change in effective income tax rate, excluding taxes on special charges and transaction and integration expenses	0.02
2022 Earnings per share – diluted	$	0.57

RESULTS OF OPERATIONS — SEGMENTS

We measure the performance of our business segments based on operating income, excluding special charges. We also exclude transaction and integration expenses related to our acquisitions of Cholula and FONA from our measure of segment performance as these expenses are similarly managed separately from the business segments. These transaction and integration expenses excluded from our segment performance measure include the amortization of the acquisition-date fair value adjustment of inventories that is included in cost of goods sold, costs directly associated with that acquisition and costs associated with integrating the businesses. See note 10 of the notes to the accompanying financial statements for additional information on our segment measures as well as for a reconciliation by segment of operating income, excluding special charges and transaction and integration expenses, to consolidated operating income. In the following discussion, we refer to our previously described measure of segment profit as segment operating income.

CONSUMER SEGMENT

24

	Three months ended
	February 28, 2022			February 28, 2021
Net sales	$	926.1		$	946.8
Percent (decrease) increase	(2.2)		%	35.4		%
Segment operating income	$	167.0		$	189.9
Segment operating income margin	18.0		%	20.1		%

In the first quarter of 2022, sales of our consumer segment decreased 2.2% as compared to the first quarter of 2021, which experienced a 35.4% increase in sales from the 2020 level, and decreased by 1.5% on a constant currency basis. That 2.2% decrease was driven by lower sales of our consumer business in the EMEA and Asia/Pacific regions, which was partially offset by growth in the Americas region, as compared to the prior year quarter. Unfavorable volume and product mix decreased consumer segment sales by 5.9% in the first quarter of 2022 as compared to the same period last year, as the exceptionally high demand that existed in the year ago period has eased but continues to reflect strong at-home consumption. Pricing actions, taken in response to increased costs, favorably impacted sales by 4.4% as compared to the prior year period. Sales in the first quarter of 2022 reflected an unfavorable impact from foreign currency rates that decreased consumer segment sales by 0.7% compared to the year-ago quarter and is excluded from our measure of sales decline of 1.5% on a constant currency basis.

In the Americas region, consumer sales increased 2.3% in the first quarter of 2022 as compared to the first quarter of 2021, which experienced a 29.8% increase in sales from the 2020 level, and increased by 2.2% on a constant currency basis. For the first quarter of 2022, unfavorable volume and product mix decreased sales by 3.3% as compared to the corresponding period in 2021, as lower private label sales and unfavorable trade replenishment were partially offset by improved branded product sales, all as compared to the prior year period. Pricing actions, taken in response to higher costs, increased sales by 5.5% as compared to the prior year period. The favorable impact of foreign currency rates increased sales by 0.1% in the quarter and is excluded from our measure of sales growth of 2.2% on a constant currency basis.

In the EMEA region, consumer sales decreased 14.2% in the first quarter of 2022 as compared to the first quarter of 2021, which experienced a 34.6% increase in sales from the 2020 level, and decreased by 9.4% on a constant currency basis. Sales were impacted by unfavorable volume and product mix during the first quarter of 2022 that decreased sales by 11.2% from the prior year level. The decrease was driven by an easing of at-home consumption as compared to the three months ended February 28, 2021. Lower sales of our homemade dessert products in France contributed to the sales decrease from the year ago quarter. Pricing actions, taken in response to the inflationary cost environment, increased sales by 1.8% as compared to the 2021 period. During the first quarter of 2022, an unfavorable impact from foreign currency rates decreased sales by 4.8% compared to the year-ago period and is excluded from our measure of sales decline of 9.4% on a constant currency basis.

In the Asia/Pacific region, consumer sales decreased 4.3% in the first quarter of 2022 as compared to the first quarter of 2021, which reflected a 64.7% increase in sales from the 2020 level, and decreased by 6.0% on a constant currency basis. For the quarter ended February 28, 2022, lower volume and unfavorable product mix decreased sales by 9.7%, driven by the exit of our rice product line in India as well as the effect of more restrictive measures relating to COVID-19 resurgences impacting Chinese new year related sales. Pricing actions, taken in response to the inflationary cost environment, increased sales by 3.7% as compared to the prior year period. A favorable impact from foreign currency rates, which increased sales by 1.7% compared to the first quarter of 2021, is excluded from our measure of sales decline of 6.0% on a constant currency basis.

Segment operating income for our consumer segment decreased by $22.9 million, or 12.1%, in the first quarter of 2022 as compared to the first quarter of 2021. The decrease in segment operating income was driven by increased commodity, transportation and conversion costs, partially offset by pricing actions in response to increased costs, CCI-led cost savings as well as a reduction in COVID-19 related costs, all as compared to the prior year period. Segment operating margin for our consumer segment decreased by 210 basis points from the first quarter of 2021 to 18.0% in the first quarter of 2022. That decrease was principally the result of a decrease in gross margin, including the margin dilutive impact of pricing actions and the impact of the inflationary cost environment, which was partially offset by CCI-led cost savings. Higher SG&A as a percentage of net sales, including increased distribution costs, also contributed to the decrease as compared to the 2021 period. On a constant currency basis, segment operating income for our consumer segment decreased by 11.9% in the first quarter of 2022 in comparison to the same period in 2021.

25

FLAVOR SOLUTIONS SEGMENT

	Three months ended
	February 28, 2022			February 28, 2021
Net sales	$	596.3		$	534.7
Percent increase	11.5		%	4.3		%
Segment operating income	$	60.1		$	72.6
Segment operating income margin	10.1		%	13.6		%

In the first quarter of 2022, sales of our flavor solutions segment increased by 11.5% as compared to the first quarter of 2021, and increased by 13.7% on a constant currency basis. The sales increase in the first quarter of 2022 included growth in all regions. The incremental impact of our FONA acquisition added 1.9% to sales in the quarter ended February 28, 2022. Favorable volume and product mix increased segment sales by 6.4% in the first quarter of 2022 as compared to the same period in 2021, due, in part, to the continued recovery of away-from-home demand. Pricing actions during the first quarter of 2022 also increased sales by 5.4%. The unfavorable impact of foreign currency rates decreased flavor solutions segment sales by 2.2% compared to the year-ago quarter and is excluded from our measure of sales growth of 13.7% on a constant currency basis.

In the Americas region, flavor solutions sales increased by 12.1% in the first quarter of 2022 as compared to the first quarter of 2021 and increased by 12.4% on a constant currency basis. Favorable volume and product mix increased flavor solutions sales in the Americas by 4.3% during the first quarter of 2022, driven by growth in sales to packaged food and beverage companies and branded foodservice customers that benefited from the continued recovery of away-from-home demand, each as compared to the year ago period. The incremental impact of the FONA acquisition increased sales by 2.7% during the first quarter of 2022. Pricing actions, taken in response to the inflationary cost environment, favorably impacted sales by 5.4% during the quarter ended February 28, 2022 as compared to the prior year period. An unfavorable impact from foreign currency rates decreased sales by 0.3% compared to the first quarter of 2021 and is excluded from our measure of sales growth of 12.4% on a constant currency basis.

In the EMEA region, flavor solutions sales increased by 15.2% in the first quarter of 2022 as compared to the first quarter of 2021 and increased by 24.2% on a constant currency basis. Favorable volume and product mix increased segment sales in the EMEA region by 17.0% as compared to the corresponding period in 2021. The increase was driven by higher sales to quick service restaurants and branded foodservice customers due, in part, to the continued recovery of away-from-home demand. Pricing actions, taken in response to the inflationary cost environment, favorably impacted sales by 7.2% in the first quarter of 2022 as compared to the prior period level. An unfavorable impact from foreign currency rates decreased sales by 9.0% compared to the first quarter of 2021 and is excluded from our measure of sales growth of 24.2% on a constant currency basis.

In the Asia/Pacific region, flavor solutions sales increased 2.5% in the first quarter of 2022 as compared to the first quarter of 2021, and increased by 4.3% on a constant currency basis. Favorable volume and product mix increased sales by 1.7% in the first quarter of 2022 driven by higher sales to quick service restaurants. Pricing actions, taken in response to the inflationary cost environment, favorably impacted sales by 2.6% as compared to the prior year period. An unfavorable impact from foreign currency rates decreased sales by 1.8% compared to the first quarter of 2021 and is excluded from our measure of sales growth of 4.3% on a constant currency basis.

Segment operating income for our flavor solutions segment decreased by $12.5 million, or 17.2%, in the first quarter of 2022 as compared to the first quarter of 2021. The decrease in segment operating income was driven by increased commodity, transportation and conversion costs, an unfavorable shift in product mix, as well as costs related to supply chain investments, which was partially offset by a higher level of sales, including pricing actions in response to the inflationary cost environment, and CCI-led cost savings, all as compared to the prior year period. Segment operating margin for our flavor solutions segment decreased by 350 basis points from the prior year level to 10.1% in the first quarter of 2022. That decrease was principally the result of a decrease in gross margin, including the margin dilutive impact of pricing actions and the impact of an inflationary cost environment, partially offset by CCI-led cost savings. On a constant currency basis, segment operating income for our flavor solutions segment decreased by 10.6% in the first quarter of 2022 as compared to the same period in 2021.

MARKET RISK SENSITIVITY

26

We utilize derivative financial instruments to enhance our ability to manage risk, including foreign exchange and interest rate exposures, which exist as part of our ongoing business operations. We do not enter into contracts for trading purposes, nor are we a party to any leveraged derivative instrument. The use of derivative financial instruments is monitored through regular communication with senior management and the utilization of written guidelines.

Foreign Exchange Risk

We are potentially exposed to foreign currency risk affecting net investments in subsidiaries, transactions (both third-party and intercompany) and earnings denominated in foreign currencies. Management assesses foreign currency risk based on transactional cash flows and translational volatility and may enter into forward contract and currency swaps with highly-rated financial institutions to reduce fluctuations in the long or short currency positions. We do not enter into contracts for trading purposes, nor are we a party to any leveraged derivative instruments. All derivatives are designated as hedges.

The following table sets forth the notional values and unrealized net gain (loss) of the portfolio of our forward foreign currency and cross currency swap contracts:

	February 28, 2022		November 30, 2021
Forward foreign currency:
Notional value	$	636.5	$	583.6
Unrealized net gain	4.9		5.5
Cross currency swaps:
Notional value	1,001.0		508.5
Unrealized net loss	(3.2)		(3.6)

The outstanding notional value is a result of our decisions on foreign currency exposure coverage, based on our foreign currency and foreign currency translation exposures.

Interest Rate Risk

We manage our interest rate exposure by entering into both fixed and variable rate debt arrangements. We also use interest rate swaps to minimize worldwide financing costs and to achieve a desired mix of fixed and variable rate debt. We do not enter into contracts for trading purposes, nor are we a party to any leveraged derivative instruments, and all derivatives are designated as hedges.

The following table sets forth the notional values and unrealized net gain (loss) of our interest rate swap contracts:

	February 28, 2022		November 30, 2021
Notional value	$	600.0	$	350.0
Unrealized net gain	14.6		23.1

The change in fair values of our interest rate swap contracts is due to changes in interest rates on the notional amounts outstanding as of each date as well as the remaining duration of our interest rate derivatives.

Commodity Risk

We purchase certain raw materials which are subject to price volatility caused by weather, market conditions, growing and harvesting conditions, governmental actions and other factors beyond our control. Our most significant raw materials are dairy products, pepper, capsicums (red peppers and paprika), onion, vanilla, garlic and salt. While future movements of raw material costs are uncertain, we respond to this volatility in a number of ways, including strategic raw material purchases, purchases of raw material for future delivery and customer price adjustments. We generally have not used derivatives to manage the volatility related to this risk.

Credit Risk

The customers of our consumer segment are predominantly food retailers and food wholesalers. Consolidations in these industries have created larger customers. In addition, competition has increased with the growth in alternative channels including mass merchandisers, dollar stores, warehouse clubs, discount chains and e-commerce. This has caused some customers to be less profitable and increased our exposure to credit risk. Some of our customers and counterparties are highly leveraged. We continue to closely monitor the credit worthiness of our customers and counterparties. We believe that our allowance for doubtful accounts properly recognizes trade receivables at realizable value. We consider nonperformance credit risk for other financial instruments to be insignificant.

27

NON-GAAP FINANCIAL MEASURES

The following table includes financial measures of adjusted gross profit, adjusted gross profit margin, adjusted operating income, adjusted operating income margin, adjusted income tax expense, adjusted income tax rate, adjusted net income and adjusted diluted earnings per share. These represent non-GAAP financial measures, which are prepared as a complement to our financial results prepared in accordance with United States generally accepted accounting principles. These financial measures exclude the impact, as applicable, of the following:

•Special charges – Special charges consist of expenses associated with certain actions undertaken by the Company to reduce fixed costs, simplify or improve processes, and improve our competitiveness and are of such significance in terms of both up-front costs and organizational/structural impact to require advance approval by our Management Committee. Upon presentation of any such proposed action (generally including details with respect to estimated costs, which typically consist principally of employee severance and related benefits, together with ancillary costs associated with the action that may include a non-cash component or a component which relates to inventory adjustments that are included in cost of goods sold; impacted employees or operations; expected timing; and expected savings) to the Management Committee and the Committee’s advance approval, expenses associated with the approved action are classified as special charges upon recognition and monitored on an on-going basis through completion.

•Transaction and integration expenses associated with the Cholula and FONA acquisitions – We exclude certain costs associated with our acquisitions of Cholula and FONA in November and December 2020, respectively, and their subsequent integration into the Company. Such costs, which we refer to as Transaction and integration expenses, include transaction costs associated with each acquisition, as well as integration costs following the respective acquisition, including the impact of the acquisition date fair value adjustment for inventories, together with the impact of discrete tax items, if any, directly related to each acquisition.

•Income from sale of unconsolidated operations — We exclude the gain realized upon our sale of an unconsolidated operation in March 2021. As more fully described in note 5 in our Annual Report on Form 10-K for the year ended November 30, 2021, the sale of our 26% interest in Eastern resulted in a gain of $13.4 million, net of tax of $5.7 million. The gain is included in Income from unconsolidated operations in our consolidated income statement for the year ended November 30, 2021.

Details with respect to the composition of transaction and integration expenses and special charges set forth below are included in note 2 of the notes to the accompanying financial statements. Details with respect to the composition of transaction and integration expenses, special charges and income from the sale of unconsolidated operations for the year ended November 30, 2021 are included in notes 2, 3 and 5, respectively, of the notes to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended November 30, 2021.

We believe that these non-GAAP financial measures are important. The exclusion of the items noted above provides additional information that enables enhanced comparisons to prior periods and, accordingly, facilitates the development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of our ongoing operations and analyze our business performance and trends.

These non-GAAP financial measures may be considered in addition to results prepared in accordance with GAAP, but they should not be considered a substitute for, or superior to, GAAP results. In addition, these non-GAAP financial measures may not be comparable to similarly titled measures of other companies because other companies may not calculate them in the same manner that we do. We intend to continue to provide these non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of these non-GAAP financial measures will provide consistency in our financial reporting.

28

A reconciliation of these non-GAAP financial measures to the related GAAP financial measures follows:

	For the year ended November 30, 2021			For the three months ended						Estimated for the year ending November 30, 2022
				February 28, 2022			February 28, 2021
Gross profit	$	2,494.6		$	560.4		$	577.5
Impact of transaction and integration expenses included in cost of goods sold (1)	6.3			—			6.3
Impact of special charges included in cost of goods sold (2)	4.7			—			—
Adjusted gross profit	$	2,505.6		$	560.4		$	583.8
Adjusted gross profit margin (3)	39.7		%	36.8		%	39.4		%
Operating income	$	1,015.1		$	206.9		$	236.3
Impact of transaction and integration expenses included in cost of goods sold (1)	6.3			—			6.3
Impact of other transaction and integration expenses (1)	29.0			0.7			18.8
Impact of special charges included in cost of goods sold (2)	4.7			—			—
Impact of other special charges (2)	46.4			19.5			1.1
Adjusted operating income	$	1,101.5		$	227.1		$	262.5
Adjusted operating income margin (4)	17.4		%	14.9		%	17.7		%
Income tax expense	$	192.7		$	34.4		$	58.6
Impact of transaction and integration expenses (1)	(2.7)			0.2			(5.9)
Impact of special charges	7.1			4.9			0.3
Adjusted income tax expense	$	197.1		$	39.5		$	53.0
Adjusted income tax rate (5)	20.1		%	19.7		%	22.7		%
Net income	$	755.3		$	154.9		$	161.8
Impact of transaction and integration expenses (1)	38.0			0.5			31.0
Impact of special charges (2)	44.0			14.6			0.8
Impact of after-tax gain on sale of unconsolidated operation	(13.4)			—			—
Adjusted net income	$	823.9		$	170.0		$	193.6
Earnings per share – diluted	$	2.80		$	0.57		$	0.60		$3.07 to $3.12
Impact of transaction and integration expenses (1)	0.14			—			0.12			0.01
Impact of special charges (2)	0.16			0.06			—			0.09
Impact of after-tax gain on sale of unconsolidated operation	(0.05)			—			—			—
Adjusted earnings per share – diluted	$	3.05		$	0.63		$	0.72		$3.17 to $3.22

29

(1)	Transaction and integration expenses include transaction and integration expenses associated with our acquisitions of Cholula and FONA. These expenses include the effect of the fair value adjustment to acquired inventories on cost of goods sold and the unfavorable impact of a discrete deferred state income tax expense item, directly related to our December 2020 acquisition of FONA, of $11.4 million or $0.04 per diluted share for the three months ended February 28, 2021, and $10.4 million or $0.04 per diluted share for the year ended November 30, 2021.
(2)	Special charges are more fully described in note 2 of notes to our accompanying consolidated financial statements. Special charges for the year ended November 30, 2021 include $4.7 million which is reflected in Cost of goods sold and an $11.2 million non-cash impairment charge associated with the impairment of certain intangible assets.
(3)	Adjusted gross profit margin is calculated as adjusted gross profit as a percentage of net sales for each period presented.
(4)	Adjusted operating income margin is calculated as adjusted operating income as a percentage of net sales for each period presented.
(5)	Adjusted income tax rate is calculated as adjusted income tax expense as a percentage of income from consolidated operations before income taxes excluding transaction and integration expenses and special charges of $200.2 million and $233.3 million for the three months ended February 28, 2022 and 2021, respectively, and $982.2 million for the year ended November 30, 2021.

Because we are a multi-national company, we are subject to variability of our reported U.S. dollar results due to changes in foreign currency exchange rates. Those changes have been volatile over the past several years. The exclusion of the effects of foreign currency exchange, or what we refer to as amounts expressed “on a constant currency basis”, is a non-GAAP measure. We believe that this non-GAAP measure provides additional information that enables enhanced comparison to prior periods excluding the translation effects of changes in rates of foreign currency exchange and provides additional insight into the underlying performance of our operations located outside of the U.S. It should be noted that our presentation herein of amounts and percentage changes on a constant currency basis does not exclude the impact of foreign currency transaction gains and losses (that is, the impact of transactions denominated in other than the local currency of any of our subsidiaries in their local currency reported results).

Percentage changes in sales and adjusted operating income expressed on a constant currency basis are presented excluding the impact of foreign currency exchange. To present this information for historical periods, current period results for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average exchange rates in effect during the corresponding period of the comparative year, rather than at the actual average exchange rates in effect during the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in the average foreign currency exchange rate between the current fiscal period and the corresponding period of the comparative year.

30

Rates of constant currency growth (decline) follow:

	Three Months Ended February 28, 2022
	Percentage Change as Reported		Impact of Foreign Currency Exchange		Percentage Change on Constant Currency Basis
Net sales:
Consumer segment:
Americas	2.3	%	0.1	%	2.2	%
EMEA	(14.2)	%	(4.8)	%	(9.4)	%
Asia/Pacific	(4.3)	%	1.7	%	(6.0)	%
Total Consumer	(2.2)	%	(0.7)	%	(1.5)	%
Flavor Solutions segment:
Americas	12.1	%	(0.3)	%	12.4	%
EMEA	15.2	%	(9.0)	%	24.2	%
Asia/Pacific	2.5	%	(1.8)	%	4.3	%
Total Flavor Solutions	11.5	%	(2.2)	%	13.7	%
Total net sales	2.8	%	(1.2)	%	4.0	%
Adjusted operating income:
Consumer segment	(12.1)	%	(0.2)	%	(11.9)	%
Flavor Solutions segment	(17.2)	%	(6.6)	%	(10.6)	%
Total adjusted operating income	(13.5)	%	(2.0)	%	(11.5)	%

To present “constant currency” information for the fiscal year 2022 projection, projected sales and adjusted operating income for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the company’s budgeted exchange rates for 2022 and are compared to the 2021 results, translated into U.S. dollars using the same 2022 budgeted exchange rates, rather than at the average actual exchange rates in effect during fiscal year 2021. To estimate the percentage change in adjusted earnings per share on a constant currency basis, a similar calculation is performed to arrive at adjusted net income divided by historical shares outstanding for fiscal year 2021 or projected shares outstanding for fiscal year 2022, as appropriate.

	Projections for the Year Ending November 30, 2022
Percentage change in net sales	3% to 5%
Impact of unfavorable foreign currency exchange	1	%
Percentage change in net sales in constant currency	4% to 6%

Percentage change in adjusted operating income	7% to 9%
Impact of unfavorable foreign currency exchange	1	%
Percentage change in adjusted operating income in constant currency	8% to 10%

Percentage change in adjusted earnings per share — diluted	4% to 6%
Impact of unfavorable foreign currency exchange	1	%
Percentage change in adjusted earnings per share in constant currency — diluted	5% to 7%

LIQUIDITY AND FINANCIAL CONDITION

	Three months ended
	February 28, 2022		February 28, 2021
Net cash provided by (used in) operating activities	$	17.9	$	(32.2)
Net cash used in investing activities	(43.7)		(755.2)
Net cash provided by financing activities	4.4		612.7

31

The primary objective of our financing strategy is to maintain a prudent capital structure that provides us flexibility to pursue our growth objectives. We use a combination of equity and short- and long-term debt. We use short-term debt, comprised primarily of commercial paper, principally to finance ongoing operations, including our requirements for working capital (accounts receivable, prepaid expenses and other current assets, and inventories, less accounts payable, accrued payroll, and other accrued liabilities). We are committed to maintaining investment grade credit ratings.

Our cash flows from operations enable us to fund operating projects and investments that are designed to meet our growth objectives, service our debt, fund or increase our quarterly dividends, fund capital projects and other investments, and make share repurchases when appropriate. Due to the cyclical nature of a portion of our business, our cash flow from operations has historically been the strongest during the fourth quarter of our fiscal year. Due to the timing of the interest payments on our debt, interest payments are higher in the first and third quarter of our fiscal year.

We believe that our sources of liquidity, which include existing cash balances, cash flows from operations, existing credit facilities, our commercial paper program, and access to capital markets, will provide sufficient liquidity to meet our debt obligations, including any repayment of debt or refinancing of debt, working capital needs, planned capital expenditures, and payment of anticipated quarterly dividends for at least the next twelve months.

In the condensed consolidated cash flow statement, the changes in operating assets and liabilities are presented excluding the translation effects of changes in foreign currency exchange rates as these do not reflect actual cash flows. In addition, in the cash flow statement, the changes in operating assets and liabilities are presented excluding the effect of acquired operating assets and liabilities, as the cash flow associated with acquisitions of businesses is presented as an investing activity. Accordingly, the amounts in the cash flow statement do not agree with changes in the operating assets and liabilities that are presented in the balance sheet.

Operating Cash Flow — Net cash provided by operating activities of $17.9 million for the three months ended February 28, 2022, increased $50.1 million from the same period of 2021. This increase was primarily driven by a lower use of cash associated with operating assets and liabilities, including the impact of lower cash used by working capital which included the impact of the payment of transaction and integration costs in the 2021 period.

As more fully described in our Annual Report on Form 10-K for the year ended November 30, 2021, we participate in a Supply Chain Financing program (SCF) with several global financial institutions (SCF Banks). Under the SCF, qualifying suppliers may elect to sell their receivables from us to an SCF Bank, enabling participating suppliers to negotiate their receivables sales arrangements directly with the respective SCF Bank. We are not party to those agreements and have no economic interest in a supplier’s decision to sell a receivable.

All outstanding amounts related to suppliers participating in the SCF are recorded within the line entitled Trade accounts payable in our condensed consolidated balance sheets, and the associated payments are included in operating activities within our consolidated statements of cash flows. As of February 28, 2022 and November 30, 2021, the amounts due to suppliers participating in the SCF and included in trade accounts payable were approximately $311.0 million and $274.3 million, respectively.

Investing Cash Flow — Cash used in investing activities of $43.7 million for the three months ended February 28, 2022 decreased by $711.5 million as compared to $755.2 million for the corresponding period in 2021. Our primary investing cash flows include the usage of cash associated with our acquisition of businesses and capital expenditures. Cash usage related to the acquisition of businesses was $706.6 million during the three months ended February 28, 2021, principally related to our acquisition of FONA. During the first three months of 2022, capital expenditures decreased by $4.9 million from the 2021 level to $43.7 million. We expect 2022 capital expenditures to approximate $320 million to support our planned growth, including the multi-year program to replace our global enterprise resource planning (ERP) system and other initiatives.

Financing Cash Flow — Financing activities provided cash of $4.4 million for the first three months of 2022, as compared to the corresponding period in 2021 when financing activities provided cash of $612.7 million. The variability between years is principally a result of changes in our net borrowings, share repurchase activity, and dividends, all as described below.

32

The following table outlines our net borrowing activities:

	Three months ended
	February 28, 2022		February 28, 2021
Net increase (decrease) in short-term borrowings	$	97.3	$	(292.4)
Proceeds from issuance of long-term debt, net of debt issuance costs	—		999.3
Repayments of long-term debt	(3.5)		(1.8)
Net cash provided from borrowing activities	$	93.8	$	705.1

During the three months ended February 28 2021, we issued $500.0 million of 0.90% notes due February 15, 2026, with net cash proceeds received of $495.7 million. We also issued $500.0 million of 1.85% notes due February 15, 2031, with net cash proceeds received of $492.8 million. The net proceeds from these issuances were used to pay down short-term borrowings, including a portion of the $1,443.0 million of commercial paper issued to fund our acquisitions of Cholula and FONA, and for general corporate purposes.

The following table outlines the activity in our share repurchase program for the three months ended February 28, 2022 and 2021 (in millions):

	2022		2021
Number of shares of common stock repurchased	0.10		—
Dollar amount	$	8.7	$	0.1

As of February 28, 2022, $567.4 million remained of the $600 million share repurchase authorization approved by the Board of Directors in November 2019. The timing and amount of any shares repurchased is determined by our management based on its evaluation of market conditions and other factors.

During the three months ended February 28, 2022, we received proceeds of $30.3 million from exercised stock options as compared to $3.6 million received in the corresponding 2021 period. We repurchased $12.0 million and $5.1 million of common stock during the three months ended February 28, 2022 and 2021, respectively, in conjunction with employee tax withholding requirements.

We increased dividends paid to $99.0 million, or a per share dividend of $0.37, in the first three months of 2022 from $90.8 million, or a per share dividend of $0.34, of dividends paid in the same period last year. The timing and amount of any future dividends is determined by our Board of Directors.

Most of our cash is in our subsidiaries outside of the U.S. We manage our worldwide cash requirements by considering available funds among the many subsidiaries through which we conduct our business and the cost effectiveness with which those funds can be accessed. Prior to the enactment of the U.S. Tax Act in December 2017, the permanent repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences; however, those balances are generally available without legal restrictions to fund ordinary business operations, capital projects and any possible future acquisitions.

At February 28, 2022 and 2021, we temporarily used $325.4 million and $221.2 million, respectively, of cash from our non-U.S. subsidiaries to pay down short-term debt in the U.S. During a quarter, our short-term borrowings vary, but are lower at the end of a quarter. The average short-term borrowings outstanding for the three months ended February 28, 2022 and 2021 were $883.4 million and $1,287.1 million, respectively. Those average short-term borrowings outstanding for the three months ended February 28, 2022 included average commercial paper outstanding of $842.0 million. Total average debt outstanding for the three months ended February 28, 2022 and 2021 was $5,438.4 million and $5,425.5 million, respectively.

The reported values of our assets and liabilities are significantly affected by fluctuations in foreign exchange rates between periods. At February 28, 2022, the exchange rates for the British pound sterling, Canadian dollar, Chinese renminbi, and Australian dollar were higher than the U.S. dollar at November 30, 2021. At February 28, 2022, the exchange rates for Euro and Polish zloty were lower than the U.S. dollar at November 30, 2021.

Credit and Capital Markets

Cash flows from operating activities are our primary source of liquidity for funding growth, dividends, capital expenditures and share repurchases. We also rely on our revolving credit facility, or borrowings backed by this facility, to fund working capital needs and other general corporate requirements.

33

In June 2021, we entered into a five-year $1.5 billion revolving credit facility, which will expire in June 2026. The current pricing for the credit facility, on a fully drawn basis, is LIBOR plus 1.25%. The pricing of the credit facility is based on a credit rating grid that contains a fully drawn maximum pricing of the credit facility equal to LIBOR plus 1.75%. The provisions of this revolving credit facility restrict subsidiary indebtedness and require us to maintain a minimum interest coverage ratio. We do not expect that this covenant would limit our access to this revolving credit facility for the foreseeable future.

We generally use our revolving credit facility to support our issuance of commercial paper. If the commercial paper market is not available or viable, we could borrow directly under our revolving credit facility. This facility is made available by a syndicate of banks, with various commitments per bank. If any of the banks in this syndicate are unable to perform on their commitments, our liquidity could be impacted, which could reduce our ability to grow through funding of our working capital. We engage in regular communication with all banks participating in our credit facility. During these communications, none of the banks have indicated that they may be unable to perform on their commitments. In addition, we periodically review our banking and financing relationships, considering the stability of the institutions and other aspects of the relationships. Based on these communications and our monitoring activities, we believe our banks will perform on their commitments.

Material Cash Requirements
We will continue to have cash requirements to support seasonal working capital needs and capital expenditures, to pay interest, to service debt, and to fund acquisitions. As part of our ongoing operations, we enter into contractual arrangements that obligate us to make future cash payments. Our primary obligations include principal and interest payments on our outstanding short-term borrowings and long-term debt. In the next year, our most significant debt service obligation is the maturity of our $750.0 million, 2.70% notes due in August 2022. Our other cash requirements include raw material purchases, lease payments, income taxes, and pension and postretirement benefits.

These obligations impact our liquidity and capital resource needs. To meet those cash requirements, we intend to use our existing cash, cash equivalents and internally generated funds, to borrow under our existing credit facility or under other short-term borrowing facilities, and depending on market conditions and upon the significance of the cost of a particular debt maturity or acquisition to our then-available sources of funds, to obtain additional short- and long-term financing. We believe that cash provided from these sources will be adequate to meet our future cash requirements.

34

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

New accounting pronouncements are issued periodically that affect our current and future operations. See note 1 of notes to the accompanying financial statements for further details of these impacts.

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS

In preparing the financial statements, we are required to make estimates and assumptions that have an impact on the assets, liabilities, revenue and expenses reported. These estimates can also affect supplemental information disclosed by us, including information about contingencies, risk and financial condition. We believe, given current facts and circumstances, our estimates and assumptions are reasonable, adhere to U.S. GAAP and are consistently applied. Inherent in the nature of an estimate or assumption is the fact that actual results may differ from estimates, and estimates may vary as new facts and circumstances arise. In preparing the financial statements, we make routine estimates and judgments in determining the net realizable value of accounts receivable, inventory, fixed assets and prepaid allowances. Our most critical accounting estimates and assumptions are included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2021.

There have been no changes in our critical accounting estimates and assumptions included in our Annual Report on Form 10-K for the fiscal year ended November 30, 2021.

FORWARD-LOOKING INFORMATION

Certain statements contained in this report, including statements concerning expected performance such as those relating to net sales, gross margin, earnings, cost savings, transaction and integration expenses, special charges, acquisitions, brand marketing support, volume and product mix, income tax expense, and the impact of foreign currency rates are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by the use of words such as “may,” “will,” “expect,” "should," "anticipate," "intend," “believe” and “plan.” These statements may relate to: the impact of the COVID-19 pandemic on our business, suppliers, consumers, customers, and employees; disruptions or inefficiencies in the supply chain, including any impact of COVID-19; the expected results of operations of businesses acquired by the company, including the acquisitions of Cholula and FONA; the expected impact of the inflationary cost environment, including commodity, packaging materials and transportation costs on our business; the expected impact of pricing actions on the company's results of operations and gross margins; the expected impact of factors affecting our supply chain, including transportation capacity, labor shortages, and absenteeism; the expected impact of productivity improvements, including those associated with our Comprehensive Continuous Improvement (CCI) program and global enablement initiative; the impact of the Russia-Ukraine conflict, including the potential for broader economic disruption; expected working capital improvements; expectations regarding growth potential in various geographies and markets, including the impact from customer, channel, category, and e-commerce expansion; expected trends in net sales and earnings performance and other financial measures; the expected timing and costs of implementing our business transformation initiative, which includes the implementation of a global enterprise resource planning (ERP) system; the expected impact of accounting pronouncements; the expectations of pension and postretirement plan contributions and anticipated charges associated with those plans; the holding period and market risks associated with financial instruments; the impact of foreign exchange fluctuations; the adequacy of internally generated funds and existing sources of liquidity, such as the availability of bank financing; the anticipated sufficiency of future cash flows to enable the payments of interest and repayment of short- and long-term debt as well as quarterly dividends and the ability to issue additional debt securities; and expectations regarding purchasing shares of McCormick's common stock under the existing repurchase authorization.

These and other forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could significantly affect expected results. Results may be materially affected by factors such as: the company's ability to drive revenue growth; the company's ability to increase pricing to offset, or partially offset, inflationary pressures on the cost of our products; damage to the company's reputation or brand name; loss of brand relevance; increased private label use; product quality, labeling, or safety concerns; negative publicity about our products; actions by, and the financial condition of, competitors and customers; the longevity of mutually beneficial relationships with our large customers; the ability to identify, interpret and react to changes in consumer preference and demand; business interruptions due to natural disasters, unexpected events or public health crises, including COVID-19; issues affecting the company's supply chain and procurement of raw materials, including fluctuations in the cost and availability of raw and packaging materials; labor shortage, turnover and labor cost increases; the impact of the Russia-Ukraine conflict, including the potential for broader economic disruption; government regulation, and changes in legal and regulatory requirements and enforcement practices; the lack of successful acquisition and integration of new businesses; global economic and financial conditions generally, including the on-going impact of the exit of the United Kingdom (U.K.) from the European Union, availability of financing, interest and inflation rates, and the imposition of tariffs, quotas, trade barriers and other similar restrictions; foreign currency fluctuations; the effects of increased level of debt service following the Cholula and FONA acquisitions as well as the effects that such

35

increased debt service may have on the company's ability to borrow or the cost of any such additional borrowing, our credit rating, and our ability to react to certain economic and industry conditions; risks associated with the phase-out of LIBOR; impairments of indefinite-lived intangible assets; assumptions we have made regarding the investment return on retirement plan assets, and the costs associated with pension obligations; the stability of credit and capital markets; risks associated with the company's information technology systems, including the threat of data breaches and cyber-attacks; the company's inability to successfully implement our business transformation initiative; fundamental changes in tax laws; including interpretations and assumptions we have made, and guidance that may be issued, and volatility in our effective tax rate; climate change; Environmental, Social and Governance (ESG) matters; infringement of intellectual property rights, and those of customers; litigation, legal and administrative proceedings; the company's inability to achieve expected and/or needed cost savings or margin improvements; negative employee relations; and other risks described in the company’s filings with the Securities and Exchange Commission.

Actual results could differ materially from those projected in the forward-looking statements. We undertake no obligation to update or revise publicly, any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For information regarding our exposure to certain market risks, see “Market Risk Sensitivity” in the Management’s Discussion and Analysis of Financial Condition and Results of Operations above and Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our Annual Report on Form 10-K for the year ended November 30, 2021. Except as described in Management’s Discussion and Analysis of Financial Condition and Results of Operations above, there have been no significant changes in our financial instrument portfolio or market risk exposures since our November 30, 2021 fiscal year end.

ITEM 4.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures: The company’s management, with the participation of the company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, the company’s Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, the company’s disclosure controls and procedures were effective.

Changes in Internal Controls: No change occurred in our “internal control over financial reporting” as defined in Rule 13a-15(f) during our last fiscal quarter which was identified in connection with the evaluation required by Rule 13a-15a as materially affecting or reasonably likely to materially affect, our internal control over financial reporting.

36

PART II – OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

There are no material pending legal proceedings in which we or our subsidiaries is a party or in which any of our or their property is the subject.

ITEM 1.ARISK FACTORS

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A to our Annual Report on Form 10-K for the fiscal year ended November 30, 2021, except as follows.

The conflict between Russia and Ukraine and the related implications may negatively impact our operations.

In February 2022, Russia invaded Ukraine. As a result, the U.S. and certain other countries have imposed sanctions on Russia and could impose further sanctions that could damage or disrupt international commerce and the global economy. It is not possible to predict the broader or longer-term consequences of this conflict or the sanctions imposed to date, which could include further sanctions, embargoes, regional instability, geopolitical shifts and adverse effects on macroeconomic conditions, security conditions, currency exchange rates and financial markets. Such geopolitical instability and uncertainty could have a negative impact on our ability to sell to, ship products to, collect payments from, and support customers in certain regions based on trade restrictions, embargoes and export control law restrictions, and logistics restrictions including closures of air space, and could increase the costs, risks and adverse impacts from supply chain and logistics challenges.

The potential effects of the conflict between Russia and Ukraine also could impact many of the other risk factors described in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended November 30, 2021. These potential effects could include but are not limited to variations in the level of our profitability, changes in laws and regulations affecting our business, fluctuations in foreign currency markets, the availability of future borrowings, the cost of borrowings, credit risks of our customers and counterparties, and potential impairment of the carrying value of goodwill or other indefinite-lived intangible assets. Given the evolving nature of this conflict, the related sanctions, potential governmental actions and economic impact, such potential impacts remain uncertain. While we expect the impacts of conflict between Russia and Ukraine to continue to have an effect on our business, financial condition and results of operations, we are unable to predict the extent or nature of these impacts at this time.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes our purchases of our Common Stock (CS) and Common Stock Non-Voting (CSNV) during the first quarter of 2022.

ISSUER PURCHASES OF EQUITY SECURITIES
Period	Total Number of Shares Purchased	Average Price Paid per share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
December 1, 2021 to December 31, 2021	CS – 34,457 (1)	$	90.48	34,457	$573 million
	CSNV – 0	$	—	—
January 1, 2022 to January 31, 2022	CS – 19,074 (2)	$	97.86	19,074	$571 million
	CSNV – 0	$	—	—
February 1, 2022 to February 28, 2022	CS – 36,681 (3)	$	100.54	36,681	$567 million
	CSNV – 0	$	—	—
Total	CS – 90,212	$	96.13	90,212	$567 million
	CSNV – 0	$	—	—

(1)On December 8, 2021 and December 14, 2021, we purchased 17,394 shares and 17,063 shares, respectively, of our CS from our U.S. defined contribution retirement plan to manage shares, based upon participant activity, in the plan's company

37

stock fund. The prices paid per share represented the closing price of the common shares on December 8, 2021 and December 14, 2021, respectively.

(2)On January 28, 2022, we purchased 19,074 shares of our CS from our U.S. defined contribution retirement plan to manage shares, based upon participant activity, in the plan's company stock fund. The price paid per share represented the closing price of the common shares on January 28, 2022.

(3)On February 4, 2022 and February 17, 2022, we purchased 17,980 shares and 16,701 shares, respectively, of our CS from our U.S. defined contribution retirement plan to manage shares, based upon participant activity, in the plan's company stock fund. The price paid per share represented the closing price of the common shares on February 4, 2022 and February 17, 2022, respectively.

As of February 28, 2022, $567.4 million remained of the $600 million share repurchase authorization approved by the Board of Directors in November 2019. The timing and amount of any shares repurchased is determined by our management based on its evaluation of market conditions and other factors.

In certain circumstances, we issue shares of CS in exchange for shares of CSNV, or issue shares of CSNV in exchange for shares of CS, in either case pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended. Typically, these exchanges are made in connection with the administration of our employee benefit plans, executive compensation programs and dividend reinvestment/direct purchase plans or at the request of holders of common stock. The number of shares issued in an exchange is generally equal to the number of shares received in the exchange, although the number may differ slightly to the extent necessary to comply with the requirements of the Employee Retirement Income Security Act of 1974. During the first quarter of 2022, we issued 703,996 shares of CSNV in exchange for shares of CS and issued 27,362 shares of CS in exchange for shares of CSNV.

ITEM 3.     DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

38

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.EXHIBITS

The following exhibits are attached or incorporated herein by reference:

	Exhibit Number		Description
(3)	(i)	Articles of Incorporation and By-Laws
		Restatement of Charter of McCormick & Company, Incorporated dated April 16, 1990	Incorporated by reference from Exhibit 4 of Registration Form S-8, Registration No. 33-39582 as filed with the Securities and Exchange Commission on March 25, 1991.
		Articles of Amendment to Charter of McCormick & Company, Incorporated dated April 1, 1992	Incorporated by reference from Exhibit 4 of Registration Form S-8, Registration Statement No. 33-59842 as filed with the Securities and Exchange Commission on March 19, 1993.
		Articles of Amendment to Charter of McCormick & Company, Incorporated dated March 27, 2003	Incorporated by reference from Exhibit 4 of Registration Form S-8, Registration Statement No. 333-104084 as filed with the Securities and Exchange Commission on March 28, 2003.
		Articles of Amendment to Charter of McCormick & Company, Incorporated dated April 2, 2021	Incorporated by reference from Exhibit 3(i) of McCormick's Form 10-Q for the quarter ended May 31, 2021, File No. 1-14920, as filed with the Securities and Exchange Commission on July 1, 2021.
	(ii)	By-Laws
		By-Laws of McCormick & Company, Incorporated Amended and Restated on November 26, 2019	Incorporated by reference from Exhibit 99.1 of McCormick's Form 8-K dated November 26, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on November 26, 2019.

(4)        Instruments defining the rights of security holders, including indentures

(i)See Exhibit 3 (Restatement of Charter and By-Laws)

(ii)Summary of Certain Exchange Rights, incorporated by reference from Exhibit 4.1 of McCormick’s Form 10-Q for the quarter ended August 31, 2001, File No. 1-14920, as filed with the Securities and Exchange Commission on October 12, 2001.

(iii)Indenture dated July 8, 2011 between McCormick and U.S. Bank National Association, incorporated by reference from Exhibit 4.1 of McCormick’s Form 8-K dated July 5, 2011, File No. 1-14920, as filed with the Securities and Exchange Commission on July 8, 2011.

(iv)Form of 2.70% Notes due 2022, incorporated by reference from Exhibit 4.2 of McCormick’s Form 8-K dated August 7, 2017, File No. 1-14920, as filed with the Securities and Exchange Commission on August 11, 2017.

(v)Form of 3.50% Notes due 2023, incorporated by reference from Exhibit 4.2 of McCormick's Form 8-K dated August 14, 2013, File No. 1-14920, as filed with the Securities and Exchange Commission on August 19, 2013.

(vi)Form of 3.15% Notes due 2024, incorporated by reference from Exhibit 4.3 of McCormick’s Form 8-K dated August 7, 2017, File No. 1-14920, as filed with the Securities and Exchange Commission on August 11, 2017.

(vii)Form of 3.25% Notes due 2025, incorporated by reference from Exhibit 4.2 of McCormick's Form 8-K dated November 3, 2015, File No. 1-14920, as filed with the Securities and Exchange Commission on November 6, 2015.

39

(viii)Form of 3.40% Notes due 2027, incorporated by reference from Exhibit 4.4 of McCormick’s Form 8-K dated August 7, 2017, File No. 1-14920, as filed with the Securities and Exchange Commission on August 11, 2017.

(ix)Form of 4.20% Notes due 2047, incorporated by reference from Exhibit 4.5 of McCormick’s Form 8-K dated August 7, 2017, File No. 1-14920, as filed with the Securities and Exchange Commission on August 11, 2017.

(x)Form of 2.50% Notes due 2030, incorporated by reference from Exhibit 4.2 of McCormick’s Form 8-K dated April 13, 2020, File No. 1-14920, as filed with the Securities and Exchange Commission on April 16, 2020.

(xi)Form of 0.90% Notes due 2026, incorporated by reference from Exhibit 4.2 of McCormick’s Form 8-K dated February 11, 2021, File No. 1-14920, as filed with the Securities and Exchange Commission on February 11, 2021.

(xii)Form of 1.85% Notes due 2031, incorporated by reference from Exhibit 4.3 of McCormick’s Form 8-K dated February 11, 2021, File No. 1-14920, as filed with the Securities and Exchange Commission on February 11, 2021.

(xiii)Description of Securities of McCormick & Company, Incorporated, incorporated by reference from Exhibit 4(xiii) of McCormick's Form 10-K for the fiscal year ended November 30, 2021, File No. 1-14920, as filed with the Securities and Exchange Commission on January 27, 2022.

(10)Material Contracts

(i)Deferred Compensation Plan, as restated on January 1, 2000, and amended on August 29, 2000, September 5, 2000 and May 16, 2003, in which directors, officers and certain other management employees participate, a copy of which Plan document and amendments was attached as Exhibit 10(viii) of McCormick’s Form 10-Q for the quarter ended August 31, 2003, File No. 1-14920, as filed with the Securities and Exchange Commission on October 14, 2003, and incorporated by reference herein.*

(ii)2004 Long-Term Incentive Plan, in which officers and certain other management employees participate, is set forth in Exhibit A of McCormick’s definitive Proxy Statement dated February 17, 2004, File No. 1-14920, as filed with the Securities and Exchange Commission on February 17, 2004, and incorporated by reference herein.*

(iii)Non-Qualified Retirement Savings Plan, with an effective date of February 1, 2017, in which directors, officers and certain other management employees participate, a copy of which Plan document was attached as Exhibit 10(v) of McCormick's Form 10-Q for the quarter ended February 28, 2017, File No. 1-14920, as filed with the Securities and Exchange Commission on March 28, 2017, and incorporated by reference herein.*    

(iv)The 2007 Omnibus Incentive Plan, in which directors, officers and certain other management employees participate, is set forth in Exhibit A of McCormick’s definitive Proxy Statement dated February 20, 2008, File No. 1-14920, as filed with the Securities and Exchange Commission on February 20, 2008, and incorporated by reference herein, as amended by Amendment No. 1 thereto, which Amendment is incorporated by reference from Exhibit 10(xi) of McCormick’s 10-K for the fiscal year ended November 30, 2008, File No. 1-14920, as filed with the Securities and Exchange Commission on January 28, 2009.*

(v)The Amended and Restated 2013 Omnibus Incentive Plan, in which directors, officers and certain other management employees participate, is incorporated by reference from Exhibit A of McCormick's definitive Proxy Statement dated February 14, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on February 14, 2019.*

40

(vi)Form of Long-Term Performance Plan Agreement, incorporated by reference from Exhibit 10(vi) of McCormick's Form 10-K for the fiscal year ended November 30, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on January 28, 2020.*        

(vii)Form of Restricted Stock Units Agreement, incorporated by reference from Exhibit 10(vii) of McCormick's Form 10-K for the fiscal year ended November 30, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on January 28, 2020.*            

(viii)Form of Restricted Stock Units Agreement for Directors, incorporated by reference from Exhibit 10(viii) of McCormick's Form 10-K for the fiscal year ended November 30, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on January 28, 2020.*    

(ix)Form of Non-Qualified Stock Option Agreement, incorporated by reference from Exhibit 10(ix) of McCormick's Form 10-K for the fiscal year ended November 30, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on January 28, 2020.*

(x)Form of Non-Qualified Stock Option Agreement for Directors, incorporated by reference from Exhibit 10(x) of McCormick's Form 10-K for the fiscal year ended November 30, 2019, File No. 1-14920, as filed with the Securities and Exchange Commission on January 28, 2020.*

(xi)Form of Stock Option Agreement for the Value Creation Acceleration Program, incorporated by reference from Exhibit 99.1 of McCormick's Form 8-K, File No. 1-14920, as filed with the Securities and Exchange Commission on December 3, 2020.*

(xii)Form of Indemnification Agreement, incorporated by reference from Exhibit 10(xv) of McCormick's Form 10-Q for the quarter ended February 28, 2014, File No. 1-14920, as filed with the Securities and Exchange Commission on March 26, 2014.*

(xiii)Employment Agreement between McCormick (UK) Limited and Malcolm Swift, incorporated by reference from Exhibit 10.1 of McCormick's Form 8-K, File No. 1-14920, as filed with the Securities and Exchange Commission on January 29, 2015.*

(xiv)Severance Plan for Executives, incorporated by reference from Exhibit 10(xix) of McCormick's Form 10-Q for the quarter ended February 28, 2015, File No. 1-14920, as filed with the Securities and Exchange Commission on March 31, 2015.*     

(31)   Rule 13a-14(a)/15d-14(a) Certifications             Filed herewith

(i)Certification of Lawrence E. Kurzius, Chairman, President and Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

(ii)Certification of Michael R. Smith, Executive Vice President and Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

(32)   Section 1350 Certifications                                 Filed herewith

(i)Certification of Lawrence E. Kurzius, Chairman, President and Chief Executive Officer, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(ii)Certification of Michael R. Smith, Executive Vice President and Chief Financial Officer, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(101) The following financial information from the Quarterly Report on Form 10-Q of McCormick for the quarter ended February 28, 2022, filed electronically herewith, and formatted in Inline XBRL (Extensible Business Reporting Language):

41

(i) Condensed Consolidated Balance Sheet; (ii) Condensed Consolidated Income Statement; (iii) Condensed Consolidated Statement of Comprehensive Income; (iv) Condensed Consolidated Cash Flow Statement; (v) Condensed Consolidated Statement of Stockholders' Equity; and (vi) Notes to the Condensed Consolidated Financial Statements.

(104) Inline XBRL for the cover page from the Quarterly Report on Form 10-Q of McCormick for the quarter ended February 28, 2022, files electronically herewith, included in the Exhibit 101 inline XBRL Document Set.

 

* Management contract or compensatory plan or arrangement.

McCormick hereby undertakes to furnish to the Securities and Exchange Commission, upon its request, copies of additional instruments of McCormick with respect to long-term debt that involve an amount of securities that do not exceed 10 percent of the total assets of McCormick and its subsidiaries on a consolidated basis, pursuant to Regulation S-K, Item 601(b)(4)(iii)(A).

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	McCORMICK & COMPANY, INCORPORATED
March 29, 2022	By:	/s/ Michael R. Smith
	Michael R. Smith
	Executive Vice President & Chief Financial Officer
March 29, 2022	By:	/s/ Gregory P. Repas
	Gregory P. Repas
	Vice President & Controller
	Principal Accounting Officer

43

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

I, Lawrence E. Kurzius, certify that:

1. I have reviewed this report on Form 10-Q of McCormick & Company, Incorporated (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 29, 2022	/s/    Lawrence E. Kurzius
	Lawrence E. Kurzius
	Chairman, President & Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

I, Michael R. Smith certify that:

1. I have reviewed this report on Form 10-Q of McCormick & Company, Incorporated (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:March 29, 2022	/s/    Michael R. Smith
	Michael R. Smith
	Executive Vice President & Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of McCormick & Company, Incorporated (the “Company”) on Form 10-Q for the period ending February 28, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lawrence E. Kurzius, Chairman, President & Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 29, 2022	/s/    Lawrence E. Kurzius
	Lawrence E. Kurzius
	Chairman, President & Chief Executive Officer

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of McCormick & Company, Incorporated (the “Company”) on Form 10-Q for the period ending February 28, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael R. Smith, Executive Vice President & Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 29, 2022	/s/     Michael R. Smith
	Michael R. Smith
	Executive Vice President & Chief Financial Officer

XML

Document and Entity Information	3 Months Ended
	Feb. 28, 2022 shares
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Feb. 28, 2022
Document Transition Report	false
Entity File Number	001-14920
Entity Registrant Name	MCCORMICK & CO INC
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	52-0408290
Entity Address, Address Line One	24 Schilling Road, Suite 1,
Entity Address, City or Town	Hunt Valley,
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	21031
City Area Code	410
Local Phone Number	771-7301
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000063754
Current Fiscal Year End Date	--11-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false
Common stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, Par Value $0.01 per share
Trading Symbol	MKC.V
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding	17,850,968
Common stock non-voting
Document Information [Line Items]
Title of 12(b) Security	Common Stock Non-Voting, Par Value $0.01 per share
Trading Symbol	MKC
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding	250,225,522

XML

CONDENSED CONSOLIDATED INCOME STATEMENT (UNAUDITED) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Net sales	$ 1,522.4	$ 1,481.5
Cost of goods sold	962.0	904.0
Gross profit	560.4	577.5
Selling, general and administrative expense	333.3	321.3
Transaction and integration expenses	0.7	18.8
Special charges	19.5	1.1
Operating income	206.9	236.3
Interest expense	33.1	33.8
Other income, net	6.2	4.6
Income from consolidated operations before income taxes	180.0	207.1
Income tax expense	34.4	58.6
Net income from consolidated operations	145.6	148.5
Income from unconsolidated operations	9.3	13.3
Net income	$ 154.9	$ 161.8
Earnings per share - basic (usd per share)	$ 0.58	$ 0.61
Earnings per share - diluted (usd per share)	$ 0.57	$ 0.60
Average shares outstanding - basic (shares)	267.8	267.1
Average shares outstanding - diluted (shares)	270.5	269.9
Common stock non-voting
Cash dividends paid per common share (usd per share)	$ 0.37	$ 0.34
Common stock
Cash dividends paid per common share (usd per share)	$ 0.37	$ 0.34

XML

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME [Abstract]
Net income	$ 154.9	$ 161.8
Net income attributable to non-controlling interest	2.5	0.8
Other comprehensive income (loss):
Unrealized components of pension and other postretirement plans	2.2	1.1
Currency translation adjustments	3.7	45.7
Change in derivative financial instruments	5.1	(1.0)
Deferred taxes	(1.0)	3.0
Comprehensive income	10.0	48.8
Comprehensive income	$ 167.4	$ 211.4

XML

CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Feb. 28, 2022	Nov. 30, 2021
ASSETS
Cash and cash equivalents	$ 338.4	$ 351.7
Trade accounts receivable, net of allowances	516.7	549.5
Inventories, net
Finished products	571.5	556.2
Raw materials and work-in-process	672.7	626.1
Total inventory	1,244.2	1,182.3
Prepaid expenses and other current assets	139.7	112.3
Total current assets	2,239.0	2,195.8
Property, plant and equipment, net	1,135.9	1,140.3
Goodwill	5,333.4	5,335.8
Intangible assets, net	3,443.7	3,452.5
Other long-term assets	788.8	781.4
Total assets	12,940.8	12,905.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Short-term borrowings	636.7	539.1
Current portion of long-term debt	770.8	770.3
Trade accounts payable	1,072.6	1,064.2
Other accrued liabilities	596.6	850.2
Total current liabilities	3,076.7	3,223.8
Long-term debt	3,964.5	3,973.3
Deferred taxes	796.5	792.3
Other long-term liabilities	488.9	490.9
Total liabilities	8,326.6	8,480.3
Shareholders’ Equity
Retained earnings	2,922.4	2,782.4
Accumulated other comprehensive loss	(416.0)	(426.5)
Total McCormick shareholders' equity	4,597.7	4,411.0
Non-controlling interests	16.5	14.5
Total shareholders’ equity	4,614.2	4,425.5
Total liabilities and shareholders’ equity	12,940.8	12,905.8
Common stock
Shareholders’ Equity
Common stock	542.1	530.0
Common stock non-voting
Shareholders’ Equity
Common stock	$ 1,549.2	$ 1,525.1

XML

CONDENSED CONSOLIDATED CASH FLOW STATEMENT (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Operating activities
Net income	$ 154.9	$ 161.8
Adjustments to reconcile net income to net cash flow provided by operating activities:
Depreciation and amortization	49.0	48.1
Stock-based compensation	11.1	14.2
Amortization of inventory fair value adjustments associated with acquisitions	0.0	6.3
Income from unconsolidated operations	(9.3)	(13.3)
Trade accounts receivable	33.2	31.0
Inventories	(49.9)	(21.5)
Trade accounts payable	5.2	(73.6)
Other assets and liabilities	(185.5)	(192.2)
Dividends from unconsolidated affiliates	9.2	7.0
Net cash flow provided by (used in) operating activities	17.9	(32.2)
Investing activities
Acquisition of businesses (net of cash acquired)	0.0	(706.6)
Capital expenditures (including software)	(43.7)	(48.6)
Net cash flow used in investing activities	(43.7)	(755.2)
Financing activities
Short-term borrowings, net	97.3	(292.4)
Long-term debt borrowings	0.0	1,000.4
Payment of debt issuance costs	0.0	(1.1)
Long-term debt repayments	(3.5)	(1.8)
Proceeds from exercised stock options	30.3	3.6
Taxes withheld and paid on employee stock awards	(12.0)	(5.1)
Common stock acquired by purchase	(8.7)	(0.1)
Dividends paid	(99.0)	(90.8)
Net cash flow provided by financing activities	4.4	612.7
Effect of exchange rate changes on cash and cash equivalents	8.1	7.2
Decrease in cash and cash equivalents	(13.3)	(167.5)
Cash and cash equivalents at beginning of period	351.7	423.6
Cash and cash equivalents at end of period	$ 338.4	$ 256.1

XML

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) shares in Millions, $ in Millions	Total	Common stock	Retained Earnings	Accumulated Other Comprehensive (Loss) Income	Non-controlling Interests	Common stock non-voting Common stock
Balance, Shares at Nov. 30, 2020		18.0				248.9
Balance, Value at Nov. 30, 2020	$ 3,940.0	$ 1,981.3	$ 2,415.6	$ (470.8)	$ 13.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	161.8		161.8
Net income attributable to non-controlling interest	0.8				0.8
Other comprehensive income (loss), net of tax	48.8			48.3	0.5
Stock-based compensation	14.2	$ 14.2
Shares purchased and retired (in shares)		(0.1)				0.0
Shares purchased and retired	(5.4)	$ (1.6)	(3.8)
Shares issued (in shares)		0.2				0.0
Shares issued	4.5	$ 4.5
Equal exchange, shares		(0.1)				0.1
Balance, Shares at Feb. 28, 2021		18.0				249.0
Balance, Value at Feb. 28, 2021	4,164.7	$ 1,998.4	2,573.6	(422.5)	15.2
Balance, Shares at Nov. 30, 2021		17.8				249.5
Balance, Value at Nov. 30, 2021	4,425.5	$ 2,055.1	2,782.4	(426.5)	14.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	154.9		154.9
Net income attributable to non-controlling interest	2.5				2.5
Other comprehensive income (loss), net of tax	10.0			10.5	(0.5)
Stock-based compensation	11.1	$ 11.1
Shares purchased and retired (in shares)		(0.2)				0.0
Shares purchased and retired	(21.4)	$ (6.5)	(14.9)
Shares issued (in shares)		0.9				0.0
Shares issued	31.6	$ 31.6
Equal exchange, shares		(0.7)				0.7
Balance, Shares at Feb. 28, 2022		17.8				250.2
Balance, Value at Feb. 28, 2022	$ 4,614.2	$ 2,091.3	$ 2,922.4	$ (416.0)	$ 16.5

XML

Accounting Policies

3 Months Ended

Feb. 28, 2022

Accounting Policies [Abstract]

Accounting Policies

ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by United States generally accepted accounting principles (U.S. GAAP) for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements contain all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position and the results of operations for the interim periods presented.

The results of consolidated operations for the three-month period ended February 28, 2022 are not necessarily indicative of the results to be expected for the full year. Historically, our net sales, net income and cash flow from operations have been lower in the first half of the fiscal year and higher in the second half. The historical increase in net sales, net income and cash flow from operations in the second half of the year has largely been due to the consumer business cycle in the U.S., where customers typically purchase more products in the fourth quarter due to the Thanksgiving and Christmas holiday seasons.

For further information, refer to the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended November 30, 2021.

Accounting Pronouncements Adopted in 2022

In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The new guidance removes certain exceptions to the general principles for income taxes and also improves consistent application of accounting by clarifying or amending existing guidance. The new standard was adopted effective December 1, 2021. There was no material impact to our consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020-04 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting that provides optional expedients for a limited period of time for accounting for contracts, hedging relationships, and other transactions affected by the London Interbank Offered Rate (LIBOR) or other reference rates expected to be discontinued. These optional expedients can be applied from March 2020 through December 31, 2022. LIBOR is used as a reference rate on our variable rate debt, including our revolving credit facility, synthetic lease, interest rate swaps, and cross currency interest rate swaps. The phase out of LIBOR reference rates will occur at different dates and began on January 1, 2022. Our adoption of this new standard occurred during the three months ended February 28, 2022, in conjunction with the first phase-out of a LIBOR reference rate. There was no material impact to our consolidated financial statements during the three months ended February 28, 2022, nor do we expect the adoption of this standard to have a material impact on our consolidated financial statements during the LIBOR transition period.

XML

Special Charges And Transaction And Integration Expenses

3 Months Ended

Feb. 28, 2022

Special Charges [Abstract]

Special Charges And Transaction And Integration Expenses

SPECIAL CHARGES AND TRANSACTION AND INTEGRATION EXPENSES

Special Charges

In our consolidated income statement, we include a separate line item captioned "Special charges" in arriving at our consolidated operating income. Special charges consist of expenses, including related impairment charges, associated with certain actions undertaken to reduce fixed costs, simplify or improve processes, and improve our competitiveness and are of such significance in terms of both up-front costs and organizational/structural impact to require advance approval by our Management Committee, comprised of our senior management, including our Chairman, President and Chief Executive Officer. Upon presentation of any such proposed action (generally including details with respect to estimated costs, which typically consist principally of employee severance and related benefits, together with ancillary costs associated with the action that may include a non-cash component, such as an asset impairment, or a component which relates to inventory adjustments that are included in cost of goods sold; impacted employees or operations; expected timing; and expected savings) to the Management Committee and the Committee’s advance approval, expenses associated with the approved action are classified as special charges upon recognition and monitored on an on-going basis through completion. Certain ancillary expenses related to these actions approved by our Management Committee do not qualify for accrual upon approval but are included as special charges as incurred during the course of the actions.

We continue to evaluate changes to our organization structure to enable us to reduce fixed costs, simplify or improve processes, and improve our competitiveness.

The following is a summary of special charges recognized in the three months ended February 28, 2022 and 2021

(in millions):

	Three months ended February 28,
	2022		2021
Employee severance and related benefits	$	14.2	$	0.3
Other costs (1)	5.3		0.8
Total	$	19.5	$	1.1

(1) Included in other costs for 2022 is non-cash accelerated depreciation of $1.4 million.

During the three months ended February 28, 2022, we recorded $19.5 million of special charges, consisting principally of $14.9 million associated with the transition of a manufacturing facility in Europe, Middle East, and Africa (EMEA), as more fully described below, streamlining actions of $2.1 million in the Americas region, and $1.5 million in the EMEA region.

In 2022, our Management Committee approved an initiative to consolidate our manufacturing operations into a net-zero carbon condiments manufacturing and distribution center facility with state-of-the-art technology in the United Kingdom. We expect to execute these changes to our supply chain operations and improve profitability, from a combination of lower headcount and non-headcount costs, by consolidating our operations into a scalable platform while expanding our capacity. We expect the cost of the initiative to approximate $30 million—to be recognized as special charges in our consolidated income statement through 2023. Of that $30 million, we expect the costs to include employee severance and related benefits, non-cash accelerated depreciation, decommissioning and other property related lease exit costs, all directly related to the initiative. During the three months ended February 28, 2022, we recorded $12.5 million in severance and related benefits costs, $1.4 million in accelerated depreciation and $1.0 million in third party expenses and other costs.

During the three months ended February 28, 2021, we recorded $1.1 million of special charges, consisting principally of streamlining actions of $0.6 million in the EMEA region and $0.5 million in the Americas region.

In 2017, our Management Committee approved a multi-year initiative during which we expect to execute significant changes to our global processes, capabilities and operating model to provide a scalable platform for future growth. We expect this initiative to enable us to accelerate our ability to work globally and cross-functionally by aligning and simplifying processes throughout McCormick, in part building upon our current shared services foundation and expanding the end-to-end processes presently under that foundation. We expect this initiative, which we refer to as Global Enablement ("GE"), to enable this scalable platform for future growth while reducing costs, enabling faster decision making, increasing agility and creating capacity within our organization.

While we are continuing to fully develop the details of our GE operating model, we expect the cost of the GE initiative—to be recognized as special charges in our consolidated income statement over its expected multi-year course—to range from approximately $60 million to $65 million. Of that $60 million to $65 million, we estimate that approximately sixty percent will be attributable to cash payments associated with the related costs of the GE implementation and transition, including outside consulting and other costs, and approximately forty percent will be attributable to severance and related benefit payments, all directly related to this initiative. We have spent a cumulative total of $40.7 million on this initiative through February 28, 2022.

As of February 28, 2022, reserves associated with special charges, which are expected to be paid during the next twelve months, are included in trade accounts payable and other accrued liabilities in our consolidated balance sheet.

The following is a breakdown by business segment of special charges for the three months ended February 28, 2022 and 2021 (in millions):

	Three months ended February 28,
	2022		2021
Consumer segment	$	3.6	$	0.8
Flavor solutions segment	15.9		0.3
Total special charges	$	19.5	$	1.1

Transaction and Integration Expenses

The following are the transaction and integration expenses recognized during the three months ended February 28, 2022 and 2021 relating to the acquisitions of Cholula Hot Sauce ("Cholula") and FONA International, LLC ("FONA") (in millions):

	2022		2021
Transaction-related expenses included in cost of goods sold	$	—	$	6.3
Other transaction expenses	—		13.8
Integration expenses	0.7		5.0
Total transaction and integration expenses	$	0.7	$	25.1

We expect transaction and integration expenses related to our acquisition of FONA to total approximately $3 million in 2022.

XML

Financial Instruments

3 Months Ended

Feb. 28, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments

FINANCIAL INSTRUMENTS

We use derivative financial instruments to enhance our ability to manage risk, including foreign currency, net investment and interest rate exposures, which exist as part of our ongoing business operations. We do not enter into contracts for trading purposes, nor are we a party to any leveraged derivative instrument, and all derivatives are designated as hedges. For the three months ended February 28, 2022 and 2021, hedge ineffectiveness was not material. We are not a party to master netting arrangements, and we do not offset the fair value of derivative contracts with the same counterparty in our financial statement disclosures. The use of derivative financial instruments is monitored through regular communication with senior management and the use of written guidelines.

Foreign currency exchange risk. We are potentially exposed to foreign currency fluctuations affecting net investments in subsidiaries, transactions (both third-party and intercompany) and earnings denominated in foreign currencies. We assess foreign currency risk based on transactional cash flows and translational volatility and may enter into forward contract and currency swaps with highly-rated financial institutions to reduce fluctuations in the long or short currency positions. Forward contracts are generally less than 18 months duration. Currency swap agreements are established in conjunction with the terms of the underlying debt issues.

At February 28, 2022, we had foreign currency exchange contracts to purchase or sell $636.5 million of foreign currencies as compared to $583.6 million at November 30, 2021. All of these contracts were designated as hedges of anticipated purchases denominated in a foreign currency or hedges of foreign currency denominated assets or liabilities. All foreign currency exchange contracts outstanding at February 28, 2022 have durations of less than 18 months, including $242.1 million of notional contracts that have durations of less than one month and are used to hedge short-term cash flow funding.

Contracts which are designated as hedges of anticipated purchases denominated in a foreign currency (generally purchases of raw materials in U.S. dollars by operating units outside the U.S.) are considered cash flow hedges. The gains and losses on these contracts are deferred in accumulated other comprehensive loss until the hedged item is recognized in cost of goods sold, at which time the net amount deferred in accumulated other comprehensive loss is also recognized in cost of goods sold. Gains and losses from contracts that are designated as hedges of assets, liabilities or firm commitments are recognized through income, offsetting the change in fair value of the hedged item.

We also enter into fair value foreign currency exchange contracts to manage both exposure to currency fluctuations in certain intercompany loans between subsidiaries as well as currency exposure to third-party non-functional currency assets or liabilities. At February 28, 2022, the notional value of these contracts was $413.4 million. Any gains or losses recorded based on both the change in fair value of these contracts and the change in the currency component of the underlying loans are recognized in our consolidated income statement as Other income, net.

We also utilize cross currency interest rate swap contracts that are designated as net investment hedges. Any gains or losses on net investment hedges are included in foreign currency translation adjustments in accumulated other comprehensive loss.

Interest rate risk. We finance a portion of our operations with both fixed and variable rate debt instruments, principally commercial paper, notes and bank loans. We utilize interest rate swap agreements to minimize worldwide financing costs and to achieve a desired mix of variable and fixed rate debt.

The following table discloses the notional amount and fair values of derivative instruments on our balance sheet (in millions):

As of February 28, 2022	Asset Derivatives					Liability Derivatives
	Balance sheet location	Notional amount		Fair value		Balance sheet location	Notional amount		Fair value
Interest rate contracts	Other current assets / Other long-term assets	$	600.0	$	14.6	Other accrued liabilities	$	—	$	—
Foreign exchange contracts	Other current assets	444.5		7.7		Other accrued liabilities	192.0		2.8
Cross currency contracts	Other current assets / Other long-term assets	495.3		10.9		Other long-term liabilities	505.7		14.1
Total				$	33.2				$	16.9
As of November 30, 2021	Asset Derivatives					Liability Derivatives
	Balance sheet location	Notional amount		Fair value		Balance sheet location	Notional amount		Fair value
Interest rate contracts	Other current assets / Other long-term assets	$	350.0	$	23.1	Other accrued liabilities	$	—	$	—
Foreign exchange contracts	Other current assets	380.8		8.3		Other accrued liabilities	202.8		2.8
Cross currency contracts	Other current assets / Other long-term assets	251.0		4.4		Other long-term liabilities	257.5		8.0
Total				$	35.8				$	10.8

During the first quarter of 2022, we entered into $250 million notional value interest rate swap contracts where we receive interest at 2.50% and pay a variable rate of interest based on USD SOFR plus 0.745%, which expire in April 2030, and are designated as fair value hedges of the changes in fair value of $250 million of the $500 million 2.50% term notes due in 2030.The fair value of these interest rate swap contracts is offset by a corresponding increase or decrease in the value of the hedged debt. Also during the first quarter of 2022, we entered into cross currency interest rate swap contracts of (i) $250 million notional value to receive $250 million at USD SOFR plus 0.745% and pay £184.1 million at GBP SONIA plus 0.5740% and (ii) £184.1 million notional value to receive £184.1 million at GBP SONIA plus 0.574% and pay €219.2 million at Euro ESTR plus 0.667%, both of which expire in April 2030. In conjunction with the phase-out of LIBOR, during the first quarter of 2022 we amended our previously existing cross currency swaps which expire in August 2027 such that, effective February 15, 2022, we now pay and receive at GBP SONIA plus 0.859% (previously GBP LIBOR plus 0.740%).

The following tables disclose the impact of derivative instruments on our other comprehensive income (OCI), accumulated other comprehensive loss (AOCI) and our consolidated income statement for the three-months ended February 28, 2022 and 2021 (in millions):

 

Fair Value Hedges
Three months ended February 28,
Derivative	Income statement location	Income (expense)
		2022		2021
Interest rate contracts	Interest expense	$	2.2	$	2.0

	Income statement location	Gain (loss) recognized in income					Income statement location	Gain (loss) recognized in income
Derivative		2022		2021		Hedged item		2022		2021
Foreign exchange contracts	Other income, net	$	(0.4)	$	(2.1)	Intercompany loans	Other income, net	$	0.4	$	2.4

The gains (losses) recognized on fair value hedges relating to currency exposure on third-party non-functional currency assets or liabilities were not material during the three-months ended February 28, 2022 and 2021.

Cash Flow Hedges
Three months ended February 28,
Derivative	Gain (loss) recognized in OCI				Income statement location	Gain (loss) reclassified from AOCI
	2022		2021			2022		2021
Interest rate contracts	$	—	$	0.3	Interest expense	$	0.1	$	0.1
Foreign exchange contracts	2.9		(1.6)		Cost of goods sold	(0.2)		0.3
Total	$	2.9	$	(1.3)		$	(0.1)	$	0.4

For all cash flow and settled interest rate fair value hedge derivatives, the net amount of accumulated other comprehensive loss expected to be reclassified in the next 12 months is $2.8 million as an increase to earnings.

Net Investment Hedges
Three months ended February 28,
Derivative	Gain (loss) recognized in OCI				Income statement location	Gain (loss) excluded from the assessment of hedge effectiveness
	2022		2021			2022		2021
Cross currency contracts	$	0.7	$	(2.0)	Interest expense	$	0.5	$	0.4

For all net investment hedges, no amounts have been reclassified out of accumulated other comprehensive loss. The amounts noted in the tables above for OCI do not include any adjustments for the impact of deferred income taxes.

XML

Fair Value Measurements

3 Months Ended

Feb. 28, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Fair value can be measured using valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

•Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

•Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

•Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

At February 28, 2022 and November 30, 2021, we had no financial assets or liabilities that were subject to a level 3 fair value measurement. Our population of financial assets and liabilities subject to fair value measurements on a recurring basis are as follows (in millions):

			February 28, 2022
	Fair Value		Level 1		Level 2
Assets
Cash and cash equivalents	$	338.4	$	338.4	$	—
Insurance contracts	126.8		—		126.8
Bonds and other long-term investments	4.1		4.1		—
Interest rate derivatives	14.6		—		14.6
Foreign currency derivatives	7.7		—		7.7
Cross currency contracts	10.9		—		10.9
Total	$	502.5	$	342.5	$	160.0
Liabilities
Foreign currency derivatives	$	2.8	$	—	$	2.8
Cross currency contracts	14.1		—		14.1
Total	$	16.9	$	—	$	16.9

 

			November 30, 2021
	Fair Value		Level 1		Level 2
Assets
Cash and cash equivalents	$	351.7	$	351.7	$	—
Insurance contracts	132.2		—		132.2
Bonds and other long-term investments	5.1		5.1		—
Interest rate derivatives	23.1		—		23.1
Foreign currency derivatives	8.3		—		8.3
Cross currency contracts	4.4		—		4.4
Total	$	524.8	$	356.8	$	168.0
Liabilities
Foreign currency derivatives	$	2.8	$	—	$	2.8
Cross currency contracts	8.0		—		8.0
Total	$	10.8	$	—	$	10.8

At February 28, 2022 and November 30, 2021, the carrying amounts of interest rate derivatives, foreign currency derivatives, cross currency contracts, insurance contracts, and bond and other long-term investments are equal to their respective fair values. Because of their short-term nature, the amounts reported in the balance sheet for cash and cash equivalents, receivables, short-

term borrowings and trade accounts payable approximate fair value. Investments in affiliates are not readily marketable, and it is not practicable to estimate their fair value.

Insurance contracts, bonds, and other long-term investments are comprised of fixed income and equity securities held for certain non-qualified U.S. employee benefit plans and are stated at fair value on the balance sheet. The fair values of insurance contracts are based upon the underlying values of the securities in which they are invested and are from quoted market prices from various stock and bond exchanges for similar type assets. The fair values of bonds and other long-term investments are based on quoted market prices from various stock and bond exchanges. The fair values for interest rate derivatives, foreign currency derivatives, and cross currency contracts are based on values for similar instruments using models with market-based inputs.

The following table sets forth the carrying amounts and fair values of our long-term debt including the current portion thereof (in millions):

	February 28, 2022		November 30, 2021
Carrying amount	$	4,735.3	$	4,743.6
Level 1 valuation techniques	$	4,571.8	$	4,722.3
Level 2 valuation techniques	196.3		199.2
Total fair value	$	4,768.1	$	4,921.5

The fair value for Level 2 long-term debt is determined by using quoted prices for similar debt instruments.

XML

Employee Benefit and Retirement Plans

3 Months Ended

Feb. 28, 2022

Retirement Benefits [Abstract]

Employee Benefit and Retirement Plans

EMPLOYEE BENEFIT AND RETIREMENT PLANS    

We sponsor defined benefit pension plans in the U.S. and certain foreign locations. In addition, we sponsor defined contribution plans in the U.S. We also contribute to defined contribution plans in locations outside the U.S., including government-sponsored retirement plans. We also currently provide postretirement medical and life insurance benefits to certain U.S. employees and retirees. We previously froze the accrual of future benefits under certain defined benefit pension plans in the U.S. and certain foreign locations. Although our defined benefit plans in the U.S., United Kingdom and Canada have generally been frozen, employees who are participants in the plans retained benefits accumulated up to the date of the freeze, based on credited service and eligible earnings, in accordance with the terms of the plans.

The following table presents the components of our pension (income) and other postretirement benefits expense for the three months ended February 28, 2022 and 2021 (in millions):

	United States pension				International pension				Other postretirement benefits
	2022		2021		2022		2021		2022		2021
Service cost	$	0.9	$	0.9	$	0.2	$	0.3	$	0.4	$	0.5
Interest costs	6.6		6.5		1.8		1.7		0.4		0.4
Expected return on plan assets	(10.7)		(10.3)		(3.2)		(3.5)		—		—
Amortization of prior service costs	0.1		0.1		—		—		(0.1)		(0.1)
Amortization of net actuarial losses	2.2		2.8		0.4		0.6		—		—
Total (income) expense	$	(0.9)	$	—	$	(0.8)	$	(0.9)	$	0.7	$	0.8

During the three months ended February 28, 2022 and 2021, we contributed $2.0 million and $2.3 million, respectively, to our pension plans. Total contributions to our pension plans in fiscal year 2021 were $15.0 million.

All of the amounts in the tables above for pension (income) and other postretirement benefits expense, other than service cost, were included in other income, net within our consolidated income statements. The net aggregate amount of pension and other postretirement benefits (income), excluding service cost components, was $(2.5) million and $(1.8) million for the three months ended February 28, 2022 and 2021, respectively.

XML

Stock-based Compensation

3 Months Ended

Feb. 28, 2022

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATIONWe have four types of stock-based compensation awards: restricted stock units ("RSUs"), stock options, company stock

awarded as part of our long-term performance plan ("LTPP") and price-vested stock options. The following table sets forth the stock-based compensation expense recorded in selling, general and administrative ("SG&A") expense (in millions):

	Three months ended February 28,
	2022		2021
Stock-based compensation expense	$	11.1	$	14.2

Our 2022 annual grant of stock options and RSUs is expected to occur in the second quarter, similar to the 2021 annual grant.

The following is a summary of our stock option activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in millions)	Number of Shares	Weighted- Average Exercise Price		Number of Shares	Weighted- Average Exercise Price
Outstanding at beginning of period	5.0	$	59.71	4.5	$	53.56
Exercised	(0.6)	45.25		(0.1)	39.30
Outstanding at end of the period	4.4	$	61.72	4.4	$	53.62
Exercisable at end of the period	3.0	$	53.17	3.2	$	47.95

As of February 28, 2022, the intrinsic value (the difference between the exercise price and the market price) for all options outstanding was $145.5 million and for options currently exercisable was $128.0 million. The total intrinsic value of all options exercised during the three months ended February 28, 2022 and 2021 was $32.6 million and $2.2 million, respectively.

The following is a summary of our RSU activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	563	$	69.52	714	$	61.74
Granted	6	92.47		10	91.85
Vested	(24)	54.02		(10)	47.70
Forfeited	(8)	78.51		(6)	65.74
Outstanding at end of period	537	$	70.31	708	$	62.34

The following is a summary of our price-vested stock options activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	2,193	$	9.40	2,482	$	9.40
Granted	—	—		15	9.66
Forfeited	(27)	9.40		(13)	9.40
Outstanding at end of period	2,166	$	9.40	2,484	$	9.40

The following is a summary of our LTPP activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	497	$	83.74	382	$	71.20
Granted	151	95.00		141	98.30
Vested	(251)	75.26		(121)	50.95
Forfeited	(2)	96.03		(5)	82.59
Outstanding at end of period	395	$	93.42	397	$	86.89

XML

Income Taxes

3 Months Ended

Feb. 28, 2022

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

Income tax expense for the three months ended February 28, 2022 included $10.3 million of net discrete tax benefits consisting principally of the following: (i) $7.6 million of excess tax benefits associated with stock-based compensation, and (ii) $2.5 million of tax benefits related to the revaluation of deferred taxes resulting from enacted legislation.

Income tax expense for the three months ended February 28, 2021 included $5.3 million of net discrete tax expense consisting principally of the following: (i) $11.4 million of deferred state tax expense directly related to our December 2020 acquisition of FONA, (ii) $4.5 million of tax benefits associated with the release of a valuation allowance due to a change in judgment about realizability of deferred tax assets, and (iii) $1.2 million of tax benefits from the reversal of certain reserves for unrecognized tax benefits associated with the resolution of tax uncertainties.

Other than additions for current year tax positions, there were no significant changes to unrecognized tax benefits during the three months ended February 28, 2022.

As of February 28, 2022, we believe the reasonably possible total amount of unrecognized tax benefits that could increase or decrease in the next 12 months as a result of various statute expirations, audit closures, and/or tax settlements would not be material to our consolidated financial statements.

XML

Capital Stock and Earnings Per Share

3 Months Ended

Feb. 28, 2022

Earnings Per Share, Basic and Diluted [Abstract]

Capital Stock and Earnings Per Share

CAPITAL STOCK AND EARNINGS PER SHARE

The following table sets forth the reconciliation of average shares outstanding (in millions):

	Three months ended February 28,
	2022	2021
Average shares outstanding – basic	267.8	267.1
Effect of dilutive securities:
Stock options/RSUs/LTPP	2.7	2.8
Average shares outstanding – diluted	270.5	269.9

The following table sets forth the stock options and RSUs that were not considered in our earnings per share calculation since they were anti-dilutive (in millions):

	Three months ended February 28,
	2022	2021
Anti-dilutive securities	0.2	—

The following table sets forth common stock activity (in millions):

	Three months ended February 28,
	2022	2021
Shares issued under stock options, RSUs, LTPP and employee stock purchase plans	0.9	0.2
Shares repurchased under the stock repurchase program and shares withheld for taxes under stock options, RSUs, and LTPP	0.2	0.1

As of February 28, 2022, $567.4 million remained of the $600 million share repurchase program authorization approved by our Board of Directors in November 2019.

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Feb. 28, 2022

Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Loss

ACCUMULATED OTHER COMPREHENSIVE LOSS

The following table sets forth the components of accumulated other comprehensive loss, net of tax, where applicable (in millions):

	February 28, 2022		November 30, 2021
Foreign currency translation adjustment (1)	$	(228.7)	$	(233.3)
Unrealized gain (loss) on foreign currency exchange contracts	5.1		0.6
Unamortized value of settled interest rate swaps	(0.4)		(0.2)
Pension and other postretirement costs	(192.0)		(193.6)
Accumulated other comprehensive loss	$	(416.0)	$	(426.5)

(1)During the three months ended February 28, 2022, the foreign currency translation adjustment of accumulated other comprehensive loss decreased on a net basis by $4.6 million, including the impact of a $0.7 million increase associated with net investment hedges. These net investment hedges are more fully described in note 3.

The following table sets forth the amounts reclassified from accumulated other comprehensive income (loss) and into consolidated net income (in millions):

	Three months ended				Affected Line Items in the Condensed Consolidated Income Statement
	February 28, 2022		February 28, 2021
(Gains)/losses on cash flow hedges:
Interest rate derivatives	$	(0.1)	$	(0.1)	Interest expense
Foreign exchange contracts	0.2		(0.3)		Cost of goods sold
Total before tax	0.1		(0.4)
Tax effect	—		0.1		Income tax expense
Net, after tax	$	0.1	$	(0.3)
Amortization of pension and postretirement benefit adjustments:
Amortization of net actuarial losses (1)	$	2.6	$	3.4	Other income, net
Total before tax	2.6		3.4
Tax effect	(0.6)		(0.8)		Income tax expense
Net, after tax	$	2.0	$	2.6

(1)This accumulated other comprehensive income (loss) component is included in the computation of total pension (income) and other postretirement benefits expense (refer to note 5 for additional details). Amortization of net actuarial losses includes settlement losses.

XML

Business Segments

3 Months Ended

Feb. 28, 2022

Segment Reporting [Abstract]

Business Segments

BUSINESS SEGMENTS

We operate in two business segments: consumer and flavor solutions. The consumer and flavor solutions segments manufacture, market and distribute spices, herbs, seasoning mixes, condiments and other flavorful products throughout the world. Our consumer segment sells to retail channels, including grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce under the “McCormick” brand and a variety of brands around the world, including “French’s”, “Frank’s RedHot”, “OLD BAY”, “Lawry’s”, “Zatarain’s”, “Simply Asia”, “Thai Kitchen”, “Ducros”, “Vahine”, “Cholula”, “Schwartz”, “Club House”, “Kamis”, “DaQiao”, “La Drogheria”, “Stubb's”, and “Gourmet Garden”. Our flavor solutions segment sells to food manufacturers and the foodservice industry both directly and indirectly through distributors, with the exception of our businesses in China and India, where foodservice sales are managed by and reported in our consumer segment.

In each of our segments, we produce and sell many individual products which are similar in composition and nature. With their primary attribute being flavor, we regard the products within each of our segments to be fairly homogenous. It is impracticable to segregate and identify sales and profits for each of these individual product lines.

We measure segment performance based on operating income excluding special charges, as this activity is managed separately from the business segments. We also exclude transaction and integration expenses related to our acquisitions, including the recent acquisitions of Cholula and FONA from our measure of segment performance as these expenses are similarly managed separately from the business segments. These transaction and integration expenses excluded from our segment performance measure include the amortization of the acquisition-date fair value adjustment of inventories that is included in cost of goods sold, costs directly associated with that acquisition and costs associated with integrating the businesses.

Although the segments are managed separately due to their distinct distribution channels and marketing strategies, manufacturing and warehousing are often integrated to maximize cost efficiencies. We do not segregate jointly utilized assets by individual segment for internal reporting, evaluating performance or allocating capital. Because of manufacturing integration for certain products within the segments, products are not sold from one segment to another but rather inventory is transferred at cost. Intersegment sales are not material.

 

	Consumer		Flavor Solutions		Total
			(in millions)
Three months ended February 28, 2022
Net sales	$	926.1	$	596.3	$	1,522.4
Operating income excluding special charges and transaction and integration expenses	167.0		60.1		227.1
Income from unconsolidated operations	8.4		0.9		9.3
Three months ended February 28, 2021
Net sales	$	946.8	$	534.7	$	1,481.5
Operating income excluding special charges and transaction and integration expenses	189.9		72.6		262.5
Income from unconsolidated operations	10.8		2.5		13.3

A reconciliation of operating income excluding special charges and transaction and integration expenses, to operating income is as follows (in millions):

	Consumer		Flavor Solutions		Total
Three months ended February 28, 2022
Operating income excluding special charges and transaction and integration expenses	$	167.0	$	60.1	$	227.1
Less: Special charges	3.6		15.9		19.5
Less: Transaction and integration expenses	—		0.7		0.7
Operating income	$	163.4	$	43.5	$	206.9
Three months ended February 28, 2021
Operating income excluding special charges and transaction and integration expenses	$	189.9	$	72.6	$	262.5
Less: Special charges	0.8		0.3		1.1
Less: Transaction-related expenses included in cost of goods sold	4.0		2.3		6.3
Less: Other transaction and integration expenses	4.2		14.6		18.8
Operating income	$	180.9	$	55.4	$	236.3

The following table sets forth our net sales, by geographic area, for the three months ended February 28, 2022 and 2021 (in millions):

	Americas		EMEA		Asia/Pacific		Total
Three months ended February 28, 2022	$	1,022.5	$	290.5	$	209.4	$	1,522.4
Three months ended February 28, 2021	964.8		302.4		214.3		1,481.5

XML

Accounting Policies (Policies)

3 Months Ended

Feb. 28, 2022

Accounting Policies [Abstract]

Accounting and disclosure charges

Accounting Pronouncements Adopted in 2022

In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The new guidance removes certain exceptions to the general principles for income taxes and also improves consistent application of accounting by clarifying or amending existing guidance. The new standard was adopted effective December 1, 2021. There was no material impact to our consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020-04 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting that provides optional expedients for a limited period of time for accounting for contracts, hedging relationships, and other transactions affected by the London Interbank Offered Rate (LIBOR) or other reference rates expected to be discontinued. These optional expedients can be applied from March 2020 through December 31, 2022. LIBOR is used as a reference rate on our variable rate debt, including our revolving credit facility, synthetic lease, interest rate swaps, and cross currency interest rate swaps. The phase out of LIBOR reference rates will occur at different dates and began on January 1, 2022. Our adoption of this new standard occurred during the three months ended February 28, 2022, in conjunction with the first phase-out of a LIBOR reference rate. There was no material impact to our consolidated financial statements during the three months ended February 28, 2022, nor do we expect the adoption of this standard to have a material impact on our consolidated financial statements during the LIBOR transition period.

XML

Special Charges And Transaction And Integration Expenses (Tables)

3 Months Ended

Feb. 28, 2022

Special Charges [Abstract]

Special Charges Summary

The following is a summary of special charges recognized in the three months ended February 28, 2022 and 2021

(in millions):

	Three months ended February 28,
	2022		2021
Employee severance and related benefits	$	14.2	$	0.3
Other costs (1)	5.3		0.8
Total	$	19.5	$	1.1

(1) Included in other costs for 2022 is non-cash accelerated depreciation of $1.4 million.

Special Charges Summary by Segment

The following is a breakdown by business segment of special charges for the three months ended February 28, 2022 and 2021 (in millions):

	Three months ended February 28,
	2022		2021
Consumer segment	$	3.6	$	0.8
Flavor solutions segment	15.9		0.3
Total special charges	$	19.5	$	1.1

Business Combination, Separately Recognized Transactions

The following are the transaction and integration expenses recognized during the three months ended February 28, 2022 and 2021 relating to the acquisitions of Cholula Hot Sauce ("Cholula") and FONA International, LLC ("FONA") (in millions):

	2022		2021
Transaction-related expenses included in cost of goods sold	$	—	$	6.3
Other transaction expenses	—		13.8
Integration expenses	0.7		5.0
Total transaction and integration expenses	$	0.7	$	25.1

XML

Financial Instruments (Tables)

3 Months Ended

Feb. 28, 2022

Fair values of derivative instruments on balance sheet

The following table discloses the notional amount and fair values of derivative instruments on our balance sheet (in millions):

As of February 28, 2022	Asset Derivatives					Liability Derivatives
	Balance sheet location	Notional amount		Fair value		Balance sheet location	Notional amount		Fair value
Interest rate contracts	Other current assets / Other long-term assets	$	600.0	$	14.6	Other accrued liabilities	$	—	$	—
Foreign exchange contracts	Other current assets	444.5		7.7		Other accrued liabilities	192.0		2.8
Cross currency contracts	Other current assets / Other long-term assets	495.3		10.9		Other long-term liabilities	505.7		14.1
Total				$	33.2				$	16.9
As of November 30, 2021	Asset Derivatives					Liability Derivatives
	Balance sheet location	Notional amount		Fair value		Balance sheet location	Notional amount		Fair value
Interest rate contracts	Other current assets / Other long-term assets	$	350.0	$	23.1	Other accrued liabilities	$	—	$	—
Foreign exchange contracts	Other current assets	380.8		8.3		Other accrued liabilities	202.8		2.8
Cross currency contracts	Other current assets / Other long-term assets	251.0		4.4		Other long-term liabilities	257.5		8.0
Total				$	35.8				$	10.8

Impact of fair value and cash flow hedges on other comprehensive income, accumulated other comprehensive income and income statement

The following tables disclose the impact of derivative instruments on our other comprehensive income (OCI), accumulated other comprehensive loss (AOCI) and our consolidated income statement for the three-months ended February 28, 2022 and 2021 (in millions):

 

Fair Value Hedges
Three months ended February 28,
Derivative	Income statement location	Income (expense)
		2022		2021
Interest rate contracts	Interest expense	$	2.2	$	2.0

	Income statement location	Gain (loss) recognized in income					Income statement location	Gain (loss) recognized in income
Derivative		2022		2021		Hedged item		2022		2021
Foreign exchange contracts	Other income, net	$	(0.4)	$	(2.1)	Intercompany loans	Other income, net	$	0.4	$	2.4

Cash Flow Hedges
Three months ended February 28,
Derivative	Gain (loss) recognized in OCI				Income statement location	Gain (loss) reclassified from AOCI
	2022		2021			2022		2021
Interest rate contracts	$	—	$	0.3	Interest expense	$	0.1	$	0.1
Foreign exchange contracts	2.9		(1.6)		Cost of goods sold	(0.2)		0.3
Total	$	2.9	$	(1.3)		$	(0.1)	$	0.4

Net Investment Hedges
Three months ended February 28,
Derivative	Gain (loss) recognized in OCI				Income statement location	Gain (loss) excluded from the assessment of hedge effectiveness
	2022		2021			2022		2021
Cross currency contracts	$	0.7	$	(2.0)	Interest expense	$	0.5	$	0.4

XML

Fair Value Measurements (Tables)

3 Months Ended

Feb. 28, 2022

Fair Value Disclosures [Abstract]

Assets and liabilities measured at fair value on recurring basis

Our population of financial assets and liabilities subject to fair value measurements on a recurring basis are as follows (in millions):

			February 28, 2022
	Fair Value		Level 1		Level 2
Assets
Cash and cash equivalents	$	338.4	$	338.4	$	—
Insurance contracts	126.8		—		126.8
Bonds and other long-term investments	4.1		4.1		—
Interest rate derivatives	14.6		—		14.6
Foreign currency derivatives	7.7		—		7.7
Cross currency contracts	10.9		—		10.9
Total	$	502.5	$	342.5	$	160.0
Liabilities
Foreign currency derivatives	$	2.8	$	—	$	2.8
Cross currency contracts	14.1		—		14.1
Total	$	16.9	$	—	$	16.9

 

			November 30, 2021
	Fair Value		Level 1		Level 2
Assets
Cash and cash equivalents	$	351.7	$	351.7	$	—
Insurance contracts	132.2		—		132.2
Bonds and other long-term investments	5.1		5.1		—
Interest rate derivatives	23.1		—		23.1
Foreign currency derivatives	8.3		—		8.3
Cross currency contracts	4.4		—		4.4
Total	$	524.8	$	356.8	$	168.0
Liabilities
Foreign currency derivatives	$	2.8	$	—	$	2.8
Cross currency contracts	8.0		—		8.0
Total	$	10.8	$	—	$	10.8

Fair Value, by Balance Sheet Grouping

The following table sets forth the carrying amounts and fair values of our long-term debt including the current portion thereof (in millions):

	February 28, 2022		November 30, 2021
Carrying amount	$	4,735.3	$	4,743.6
Level 1 valuation techniques	$	4,571.8	$	4,722.3
Level 2 valuation techniques	196.3		199.2
Total fair value	$	4,768.1	$	4,921.5

XML

Employee Benefit and Retirement Plans (Tables)

3 Months Ended

Feb. 28, 2022

Retirement Benefits [Abstract]

Schedule of defined benefit plans disclosures

The following table presents the components of our pension (income) and other postretirement benefits expense for the three months ended February 28, 2022 and 2021 (in millions):

	United States pension				International pension				Other postretirement benefits
	2022		2021		2022		2021		2022		2021
Service cost	$	0.9	$	0.9	$	0.2	$	0.3	$	0.4	$	0.5
Interest costs	6.6		6.5		1.8		1.7		0.4		0.4
Expected return on plan assets	(10.7)		(10.3)		(3.2)		(3.5)		—		—
Amortization of prior service costs	0.1		0.1		—		—		(0.1)		(0.1)
Amortization of net actuarial losses	2.2		2.8		0.4		0.6		—		—
Total (income) expense	$	(0.9)	$	—	$	(0.8)	$	(0.9)	$	0.7	$	0.8

XML

Stock-Based Compensation (Tables)

3 Months Ended

Feb. 28, 2022

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Based Compensation in Selling, General and Administrative Expense

The following table sets forth the stock-based compensation expense recorded in selling, general and administrative ("SG&A") expense (in millions):

	Three months ended February 28,
	2022		2021
Stock-based compensation expense	$	11.1	$	14.2

Summary of Option Activity

The following is a summary of our stock option activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in millions)	Number of Shares	Weighted- Average Exercise Price		Number of Shares	Weighted- Average Exercise Price
Outstanding at beginning of period	5.0	$	59.71	4.5	$	53.56
Exercised	(0.6)	45.25		(0.1)	39.30
Outstanding at end of the period	4.4	$	61.72	4.4	$	53.62
Exercisable at end of the period	3.0	$	53.17	3.2	$	47.95

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

The following is a summary of our RSU activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	563	$	69.52	714	$	61.74
Granted	6	92.47		10	91.85
Vested	(24)	54.02		(10)	47.70
Forfeited	(8)	78.51		(6)	65.74
Outstanding at end of period	537	$	70.31	708	$	62.34

Schedule of Share Based Compensation, Performance Shares, Activity

The following is a summary of our LTPP activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	497	$	83.74	382	$	71.20
Granted	151	95.00		141	98.30
Vested	(251)	75.26		(121)	50.95
Forfeited	(2)	96.03		(5)	82.59
Outstanding at end of period	395	$	93.42	397	$	86.89

Price Vested Stock Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Payment Arrangement, Activity

The following is a summary of our price-vested stock options activity for the three months ended February 28, 2022 and 2021:

	2022			2021
(shares in thousands)	Number of Shares	Weighted- Average Grant-Date Fair Value		Number of Shares	Weighted- Average Grant-Date Fair Value
Outstanding at beginning of period	2,193	$	9.40	2,482	$	9.40
Granted	—	—		15	9.66
Forfeited	(27)	9.40		(13)	9.40
Outstanding at end of period	2,166	$	9.40	2,484	$	9.40

XML

Capital Stock and Earnings Per Share (Tables)

3 Months Ended

Feb. 28, 2022

Earnings Per Share, Basic and Diluted [Abstract]

Reconciliation of average shares outstanding

The following table sets forth the reconciliation of average shares outstanding (in millions):

	Three months ended February 28,
	2022	2021
Average shares outstanding – basic	267.8	267.1
Effect of dilutive securities:
Stock options/RSUs/LTPP	2.7	2.8
Average shares outstanding – diluted	270.5	269.9

Anti-dilutive securities not considered in earnings per share calculation

The following table sets forth the stock options and RSUs that were not considered in our earnings per share calculation since they were anti-dilutive (in millions):

	Three months ended February 28,
	2022	2021
Anti-dilutive securities	0.2	—

Common stock activity

The following table sets forth common stock activity (in millions):

	Three months ended February 28,
	2022	2021
Shares issued under stock options, RSUs, LTPP and employee stock purchase plans	0.9	0.2
Shares repurchased under the stock repurchase program and shares withheld for taxes under stock options, RSUs, and LTPP	0.2	0.1

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Feb. 28, 2022

Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of accumulated other comprehensive income (loss)

The following table sets forth the components of accumulated other comprehensive loss, net of tax, where applicable (in millions):

	February 28, 2022		November 30, 2021
Foreign currency translation adjustment (1)	$	(228.7)	$	(233.3)
Unrealized gain (loss) on foreign currency exchange contracts	5.1		0.6
Unamortized value of settled interest rate swaps	(0.4)		(0.2)
Pension and other postretirement costs	(192.0)		(193.6)
Accumulated other comprehensive loss	$	(416.0)	$	(426.5)

Reclassification out of Accumulated Other Comprehensive Income

The following table sets forth the amounts reclassified from accumulated other comprehensive income (loss) and into consolidated net income (in millions):

	Three months ended				Affected Line Items in the Condensed Consolidated Income Statement
	February 28, 2022		February 28, 2021
(Gains)/losses on cash flow hedges:
Interest rate derivatives	$	(0.1)	$	(0.1)	Interest expense
Foreign exchange contracts	0.2		(0.3)		Cost of goods sold
Total before tax	0.1		(0.4)
Tax effect	—		0.1		Income tax expense
Net, after tax	$	0.1	$	(0.3)
Amortization of pension and postretirement benefit adjustments:
Amortization of net actuarial losses (1)	$	2.6	$	3.4	Other income, net
Total before tax	2.6		3.4
Tax effect	(0.6)		(0.8)		Income tax expense
Net, after tax	$	2.0	$	2.6

(1)This accumulated other comprehensive income (loss) component is included in the computation of total pension (income) and other postretirement benefits expense (refer to note 5 for additional details). Amortization of net actuarial losses includes settlement losses.

XML

Business Segments (Tables)

3 Months Ended

Feb. 28, 2022

Segment Reporting [Abstract]

Business segments

	Consumer		Flavor Solutions		Total
			(in millions)
Three months ended February 28, 2022
Net sales	$	926.1	$	596.3	$	1,522.4
Operating income excluding special charges and transaction and integration expenses	167.0		60.1		227.1
Income from unconsolidated operations	8.4		0.9		9.3
Three months ended February 28, 2021
Net sales	$	946.8	$	534.7	$	1,481.5
Operating income excluding special charges and transaction and integration expenses	189.9		72.6		262.5
Income from unconsolidated operations	10.8		2.5		13.3

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

A reconciliation of operating income excluding special charges and transaction and integration expenses, to operating income is as follows (in millions):

	Consumer		Flavor Solutions		Total
Three months ended February 28, 2022
Operating income excluding special charges and transaction and integration expenses	$	167.0	$	60.1	$	227.1
Less: Special charges	3.6		15.9		19.5
Less: Transaction and integration expenses	—		0.7		0.7
Operating income	$	163.4	$	43.5	$	206.9
Three months ended February 28, 2021
Operating income excluding special charges and transaction and integration expenses	$	189.9	$	72.6	$	262.5
Less: Special charges	0.8		0.3		1.1
Less: Transaction-related expenses included in cost of goods sold	4.0		2.3		6.3
Less: Other transaction and integration expenses	4.2		14.6		18.8
Operating income	$	180.9	$	55.4	$	236.3

Schedule of Disclosure on Geographic Areas

The following table sets forth our net sales, by geographic area, for the three months ended February 28, 2022 and 2021 (in millions):

	Americas		EMEA		Asia/Pacific		Total
Three months ended February 28, 2022	$	1,022.5	$	290.5	$	209.4	$	1,522.4
Three months ended February 28, 2021	964.8		302.4		214.3		1,481.5

XML

Special Charges And Transaction And Integration Expenses (Details) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Special Charges [Line Items]
Special charges	$ 19.5	$ 1.1
Transaction and integration expenses	0.7	18.8
Integration expenses	0.7	5.0
Total transaction and integration expenses	0.7	25.1
Estimated future integration costs	3.0
Cost of goods sold
Special Charges [Line Items]
Transaction and integration expenses	0.0	6.3
Other transaction expenses
Special Charges [Line Items]
Transaction and integration expenses	0.0	13.8
Consumer
Special Charges [Line Items]
Special charges	3.6	0.8
Transaction and integration expenses	0.0	4.2
Consumer | Cost of goods sold
Special Charges [Line Items]
Transaction and integration expenses		4.0
Flavor Solutions
Special Charges [Line Items]
Special charges	15.9	0.3
Transaction and integration expenses	0.7	14.6
Flavor Solutions | Cost of goods sold
Special Charges [Line Items]
Transaction and integration expenses		2.3
Employee severance and related benefits
Special Charges [Line Items]
Special charges	14.2	0.3
Other costs (1)
Special Charges [Line Items]
Special charges	5.3	0.8
Total
Special Charges [Line Items]
Special charges	19.5	1.1
Total | Consumer
Special Charges [Line Items]
Special charges	3.6	0.8
Total | Flavor Solutions
Special Charges [Line Items]
Special charges	15.9	0.3
EMEA
Special Charges [Line Items]
Special charges	1.5	0.6
special charges depreciation	1.4
EMEA | Manufacturing Facility
Special Charges [Line Items]
Special charges	14.9
Special charges forecasted cost	30.0
Severance costs	12.5
Restructuring and related cost, accelerated depreciation	1.4
Other restructuring costs	1.0
Americas
Special Charges [Line Items]
Special charges	2.1	$ 0.5
GE_Project
Special Charges [Line Items]
Special Charges cash paid	40.7
GE_Project | Minimum
Special Charges [Line Items]
Special charges	60.0
GE_Project | Maximum
Special Charges [Line Items]
Special charges	$ 65.0

XML

Financial Instruments - Additional Information (Details)	3 Months Ended
	Feb. 28, 2022 USD ($)	Feb. 28, 2022 GBP (£)	Feb. 28, 2022 EUR (€)	Nov. 30, 2021 USD ($)
Debt Instrument [Line Items]
Investment foreign currency, contract, foreign currency amount	$ 636,500,000			$ 583,600,000
Maximum time frame for foreign exchange contracts, months	18 months
Total derivative assets, Fair Value	$ 33,200,000			$ 35,800,000
Amount of accumulated other comprehensive income expected to be reclassified to earnings in next 12 months	$ 2,800,000
2.5% Notes due April 2030
Debt Instrument [Line Items]
Stated note interest rate	2.50%	2.50%	2.50%
Short-term Contract with Customer
Debt Instrument [Line Items]
Investment foreign currency, contract, foreign currency amount	$ 242,100,000
Fair Value Hedges | Foreign exchange contracts
Debt Instrument [Line Items]
Derivative, notional amount	413,400,000
Net Investment Hedges | Cross currency contracts
Debt Instrument [Line Items]
Derivative, notional amount	250,000,000
Total derivative assets, Fair Value	250,000,000
Derivative, collateral, obligation to return cash | £		£ 184,100,000
Net Investment Hedges | Cross currency contract II
Debt Instrument [Line Items]
Derivative, notional amount | £		184,100,000
Total derivative assets, Fair Value | £		£ 184,100,000
Derivative, collateral, obligation to return cash | €			€ 219,200,000
Interest Rate Swap | Treasury Lock
Debt Instrument [Line Items]
Derivative, notional amount	$ 250,000,000
Interest Rate Swap | Treasury Lock | 2.5% Notes due April 2030
Debt Instrument [Line Items]
Derivative, fixed interest rate	2.50%	2.50%	2.50%
Derivative, basis spread on variable rate	0.745%	0.745%	0.745%
Interest Rate Swap 3.25% | Treasury Lock | 2.5% Notes due April 2030
Debt Instrument [Line Items]
Derivative, notional amount	$ 250,000,000
Notes payable	$ 500,000,000
Great Britain SONIA | Net Investment Hedges | Cross currency contracts
Debt Instrument [Line Items]
Derivative, variable interest rate	0.859%	0.859%	0.859%
Great Britain SONIA | Interest Rate Swap 3.40% | Treasury Lock
Debt Instrument [Line Items]
Derivative, basis spread on variable rate	0.574%	0.574%	0.574%
EURO ESTR | Net Investment Hedges | Cross currency contract II
Debt Instrument [Line Items]
Derivative, variable interest rate	0.667%	0.667%	0.667%
Great Britain LIBOR | Net Investment Hedges | Cross currency contracts
Debt Instrument [Line Items]
Derivative, variable interest rate	0.74%	0.74%	0.74%

XML

Financial Instruments - Fair Value of Derivative Instruments on Balance Sheet (Detail) - USD ($)	Feb. 28, 2022	Nov. 30, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total derivative assets, Fair Value	$ 33,200,000	$ 35,800,000
Total derivative liabilities, Fair Value	16,900,000	10,800,000
Interest rate contracts | Other Long-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset, Notional Amount	600,000,000.0	350,000,000.0
Interest rate contracts, Fair Value		23,100,000
Interest rate contracts | Other accrued liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate contracts, Fair Value	0
Derivative Liability, Notional Amount	0	0
Foreign exchange contracts | Other current assets / Other long-term assets
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset, Notional Amount	444,500,000	380,800,000
Foreign exchange contracts | Other accrued liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability, Notional Amount	192,000,000.0	202,800,000
Cross currency contracts | Other Long-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset, Notional Amount	495,300,000	251,000,000.0
Cross currency contracts | Other accrued liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability, Notional Amount	505,700,000	257,500,000
Fair Value, Measurements, Recurring | Interest rate contracts | Other Long-term Investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate contracts, Fair Value	14,600,000
Fair Value, Measurements, Recurring | Interest rate contracts | Other accrued liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate contracts, Fair Value		0
Fair Value, Measurements, Recurring | Foreign exchange contracts | Other current assets / Other long-term assets
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency derivatives	7,700,000	8,300,000
Fair Value, Measurements, Recurring | Foreign exchange contracts | Other accrued liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign currency derivatives	2,800,000	2,800,000
Fair Value, Measurements, Recurring | Cross currency contracts | Assets
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cross currency contracts	10,900,000	4,400,000
Fair Value, Measurements, Recurring | Cross currency contracts | Liability
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cross currency contracts	$ 14,100,000	$ 8,000,000.0

XML

Financial Instruments - Impact of Fair Value Hedges on Other Comprehensive Income, Accumulated Other Comprehensive Income and Income Statement (Details) - Fair Value Hedges - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Interest expense | Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Interest income (expense)	$ 2.2	$ 2.0
Other income, net | Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	(0.4)	(2.1)
Other income, net | Intercompany loans
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	$ 0.4	$ 2.4

XML

Financial Instruments - Impact of Cash Flow Hedges on Other Comprehensive Income, Accumulated Other Comprehensive Income and Income Statement (Details) - USD ($)	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	$ 2,900,000	$ (1,300,000)
Gain (loss) reclassified from AOCI / Gain (loss) excluded from the assessment of hedge effectiveness	(100,000)	400,000
Cash Flow Hedges | Interest rate contracts | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	0	300,000
Gain (loss) reclassified from AOCI / Gain (loss) excluded from the assessment of hedge effectiveness	100,000	100,000
Cash Flow Hedges | Foreign exchange contracts | Cost of goods sold
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	2,900,000	(1,600,000)
Gain (loss) reclassified from AOCI / Gain (loss) excluded from the assessment of hedge effectiveness	(200,000)	300,000
Net Investment Hedges | Cross currency contracts | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	700,000	(2,000,000.0)
Gain (loss) reclassified from AOCI / Gain (loss) excluded from the assessment of hedge effectiveness	$ 500,000	$ 400,000

XML

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)	Feb. 28, 2022	Nov. 30, 2021
Assets
Cash and cash equivalents at fair value	$ 338,400,000	$ 351,700,000
Liabilities
Long-term debt	4,735,300,000	4,743,600,000
Long-term debt, fair value	4,768,100,000	4,921,500,000
Level 1
Liabilities
Long-term debt, fair value	4,571,800,000	4,722,300,000
Level 2
Liabilities
Long-term debt, fair value	196,300,000	199,200,000
Fair Value, Measurements, Recurring
Assets
Cash and cash equivalents at fair value		351,700,000
Insurance contracts	126,800,000	132,200,000
Bonds and other long-term investments	4,100,000	5,100,000
Total	502,500,000	524,800,000
Liabilities
Total	16,900,000	10,800,000
Fair Value, Measurements, Recurring | Level 1
Assets
Cash and cash equivalents	338,400,000	351,700,000
Insurance contracts	0	0
Bonds and other long-term investments	4,100,000	5,100,000
Interest rate derivatives	0	0
Foreign currency derivatives	0	0
Total	342,500,000	356,800,000
Liabilities
Foreign currency derivatives	0	0
Cross currency contracts	0	0
Total	0	0
Fair Value, Measurements, Recurring | Level 2
Assets
Cash and cash equivalents	0	0
Insurance contracts	126,800,000	132,200,000
Bonds and other long-term investments	0	0
Interest rate derivatives	14,600,000	23,100,000
Foreign currency derivatives	7,700,000	8,300,000
Total	160,000,000.0	168,000,000.0
Liabilities
Foreign currency derivatives	2,800,000	2,800,000
Cross currency contracts	14,100,000	8,000,000.0
Total	16,900,000	10,800,000
Assets | Fair Value, Measurements, Recurring | Level 1
Assets
Cross currency contracts	0	0
Assets | Fair Value, Measurements, Recurring | Level 2
Assets
Cross currency contracts	10,900,000	4,400,000
Interest rate contracts | Other Long-term Investments
Assets
Interest rate contracts, Fair Value		23,100,000
Interest rate contracts | Other Long-term Investments | Fair Value, Measurements, Recurring
Assets
Interest rate contracts, Fair Value	14,600,000
Interest rate contracts | Other accrued liabilities
Assets
Interest rate contracts, Fair Value	0
Interest rate contracts | Other accrued liabilities | Fair Value, Measurements, Recurring
Assets
Interest rate contracts, Fair Value		0
Foreign exchange contracts | Other current assets / Other long-term assets | Fair Value, Measurements, Recurring
Assets
Foreign currency derivatives	7,700,000	8,300,000
Foreign exchange contracts | Other accrued liabilities | Fair Value, Measurements, Recurring
Assets
Foreign currency derivatives	2,800,000	2,800,000
Cross currency contracts | Assets | Fair Value, Measurements, Recurring
Assets
Cross currency contracts	10,900,000	4,400,000
Cross currency contracts | Liability | Fair Value, Measurements, Recurring
Liabilities
Cross currency contracts	$ 14,100,000	$ 8,000,000.0

XML

Employee Benefit And Retirement Plans - Components of Pension Expense of Defined benefit plans (Detail) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Defined Benefit Plan Disclosure [Line Items]
Other income, net	$ 6.2	$ 4.6
United States pension
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.9	0.9
Interest costs	6.6	6.5
Expected return on plan assets	(10.7)	(10.3)
Amortization of prior service costs	0.1	0.1
Amortization of net actuarial losses	2.2	2.8
Total pension expense	(0.9)	0.0
International pension
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.2	0.3
Interest costs	1.8	1.7
Expected return on plan assets	(3.2)	(3.5)
Amortization of prior service costs	0.0	0.0
Amortization of net actuarial losses	0.4	0.6
Total pension expense	$ (0.8)	$ (0.9)

XML

Employee Benefit and Retirement Plans - Components of Other Postretirement Benefit Expenses (Details) - Other postretirement benefits - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	$ 0.4	$ 0.5
Interest costs	0.4	0.4
Expected return on plan assets	0.0	0.0
Amortization of prior service costs	(0.1)	(0.1)
Amortization of net actuarial losses	0.0	0.0
Total other postretirement expense	$ 0.7	$ 0.8

XML

Employee Benefit And Retirement Plans - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Nov. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Payment for pension benefits	$ 2.0	$ 2.3	$ 15.0
Other income, net	6.2	4.6
Accounting Standards Update 2017-07
Defined Benefit Plan Disclosure [Line Items]
Other income, net	$ (2.5)	$ (1.8)

XML

Stock-Based Compensation - Additional Information (Detail) $ in Millions	3 Months Ended
	Feb. 28, 2022 USD ($) award_type	Feb. 28, 2021 USD ($)
Share-based Payment Arrangement [Abstract]
Number of stock-based compensation award types | award_type	4
Intrinsic value for all options outstanding	$ 145.5
Intrinsic value for exercisable options	128.0
Total Intrinsic Value of all options exercised	$ 32.6	$ 2.2

XML

Stock-Based Compensation - Selling, General and Administrative Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Share-based Payment Arrangement [Abstract]
Total stock-based compensation expense	$ 11.1	$ 14.2

XML

Stock-Based Compensation - Summary of Stock Option Activity (Details) - Stock Options - $ / shares shares in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period, Number of Shares	5.0	4.5
Exercised, Number of Shares	(0.6)	(0.1)
Outstanding at end of period, Number of Shares	4.4	4.4
Excercisable at end of the period, Number of Shares	3.0	3.2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at beginning of period, Weighted-Average Exercise Price	$ 59.71	$ 53.56
Exercised, Weighted-Average Exercise Price	45.25	39.30
Outstanding at end of period, Weighted-Average Exercise Price	61.72	53.62
Exercisable at end of the period, Weighted-Average Exercise Price	$ 53.17	$ 47.95

XML

Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) - $ / shares shares in Thousands	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding at beginning of period, Number of Shares	563	714
Granted, Number of Shares	6	10
Vested, Number of Shares	(24)	(10)
Forfeited, Number of Shares	(8)	(6)
Outstanding at end of period, Number of Shares	537	708
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Outstanding at beginning of period, Weighted-Average Grant-Date Fair Value	$ 69.52	$ 61.74
Granted, Weighted-Average Grant-Date Fair Value	92.47	91.85
Vested, Weighted-Average Grant-Date Fair Value	54.02	47.70
Forfeited, Weighted-Average Grant-Date Fair Value	78.51	65.74
Outstanding at end of period, Weighted-Average Grant-Date Fair Value	$ 70.31	$ 62.34

XML

Stock-Based Compensation - Summary of Price-Vested Stock Options Activity (Details) - Price Vested Stock Options - $ / shares shares in Thousands	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding at beginning of period, Number of Shares	2,193	2,482
Granted, Number of Shares	0	15
Forfeited, Number of Shares	(27)	(13)
Outstanding at end of period, Number of Shares	2,166	2,484
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Outstanding at beginning of period, Weighted-Average Grant-Date Fair Value	$ 9.40	$ 9.40
Granted, Weighted-Average Grant-Date Fair Value	0	9.66
Forfeited, Weighted-Average Grant-Date Fair Value	9.40	9.40
Outstanding at end of period, Weighted-Average Grant-Date Fair Value	$ 9.40	$ 9.40

XML

Stock-Based Compensation - Summary of LTPP awards (Details) - Performance Shares - $ / shares shares in Thousands	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding at beginning of period, Number of Shares	497	382
Granted, Number of Shares	151	141
Vested, Number of Shares	(251)	(121)
Forfeited, Number of Shares	(2)	(5)
Outstanding at end of period, Number of Shares	395	397
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Outstanding at beginning of period, Weighted-Average Grant-Date Fair Value	$ 83.74	$ 71.20
Granted, Weighted-Average Grant-Date Fair Value	95.00	98.30
Vested, Weighted-Average Grant-Date Fair Value	75.26	50.95
Forfeited, Weighted-Average Grant-Date Fair Value	96.03	82.59
Outstanding at end of period, Weighted-Average Grant-Date Fair Value	$ 93.42	$ 86.89

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation, tax credit, amount	$ 10.3	$ 5.3
Shares issued, tax benefit	7.6
Tax benefits related to the revaluation of deferred taxes	$ 2.5
Unrecognized tax benefits, decrease resulting from acquisition		11.4
Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount		4.5
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations		$ 1.2

XML

Capital Stock and Earnings Per Share - Reconciliation of Average Shares Outstanding (Details) - shares shares in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Earnings Per Share, Basic and Diluted [Abstract]
Average shares outstanding - basic (shares)	267.8	267.1
Effect of dilutive securities: [Abstract]
Stock options/RSUs/LTPP	2.7	2.8
Average shares outstanding – diluted (shares)	270.5	269.9

XML

Capital Stock and Earnings Per Share - Antidilutive Securities not Considered in Earnings Per Share Calculation (Details) - shares shares in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Earnings Per Share, Basic and Diluted [Abstract]
Anti-dilutive securities	0.2	0.0

XML

Capital Stock and Earnings Per Share - Common Stock Activity (Details) - shares shares in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Stock Options And Restricted Stock Units
Employee Stock Purchase Plan [Line Items]
Shares issued under stock options, RSUs, LTPP and employee stock purchase plans	0.9	0.2
Share Repurchase Program
Employee Stock Purchase Plan [Line Items]
Shares repurchased under the stock repurchase program and shares withheld for taxes under stock options, RSUs, and LTPP	0.2	0.1

XML

Capital Stock and Earnings Per Share - Additional Information (Details) - November 2019 $ in Millions	Feb. 28, 2022 USD ($)
Class of Stock [Line Items]
Stock repurchase program, remaining authorized repurchase amount	$ 567.4
Stock repurchase program, authorized amount	$ 600.0

XML

Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income, Net of Tax (Details) (Details) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Nov. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency translation adjustment	$ (228.7)	$ (233.3)
Unrealized gain (loss) on foreign currency exchange contracts	5.1	0.6
Unamortized value of settled interest rate swaps	(0.4)	(0.2)
Pension and other postretirement costs	(192.0)	(193.6)
Accumulated other comprehensive loss	(416.0)	$ (426.5)
Decrease in foreign currency translation adjustment	4.6
Cross currency contracts
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency translation adjustment	$ 0.7

XML

Accumulated Other Comprehensive Loss - Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) Into Consolidated Net Income (Details) - USD ($)	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Interest expense	$ 33,100,000	$ 33,800,000
Cost of goods sold	962,000,000.0	904,000,000.0
Other income, net	6,200,000	4,600,000
Tax effect	34,400,000	58,600,000
Net, after tax	154,900,000	161,800,000
Reclassification out of Accumulated Other Comprehensive Income | (Gains)/losses on cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Total before tax	100,000	(400,000)
Tax effect	0	100,000
Net, after tax	100,000	(300,000)
Reclassification out of Accumulated Other Comprehensive Income | Amortization of pension and postretirement benefit adjustments:
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other income, net	2,600,000	3,400,000
Total before tax	2,600,000	3,400,000
Tax effect	(600,000)	(800,000)
Net, after tax	2,000,000.0	2,600,000
Interest rate contracts | Reclassification out of Accumulated Other Comprehensive Income | (Gains)/losses on cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Interest expense	(100,000)	(100,000)
Foreign exchange contracts | Reclassification out of Accumulated Other Comprehensive Income | (Gains)/losses on cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of goods sold	$ 200,000	$ (300,000)

XML

Business Segments - Additional Information (Detail)	3 Months Ended
	Feb. 28, 2022 segment
Segment Reporting [Abstract]
Number of operating segments	2

XML

Business Segments (Detail) - USD ($) $ in Millions	3 Months Ended
	Feb. 28, 2022	Feb. 28, 2021
Segment Reporting Information [Line Items]
Revenues	$ 1,522.4	$ 1,481.5
Operating income excluding special charges and transaction and integration expenses	227.1	262.5
Income from unconsolidated operations	9.3	13.3
Less: Special charges	19.5	1.1
Transaction and integration expenses	0.7	18.8
Operating income	206.9	236.3
Cost of goods sold
Segment Reporting Information [Line Items]
Transaction and integration expenses	0.0	6.3
Consumer
Segment Reporting Information [Line Items]
Revenues	926.1	946.8
Operating income excluding special charges and transaction and integration expenses	167.0	189.9
Income from unconsolidated operations	8.4	10.8
Less: Special charges	3.6	0.8
Transaction and integration expenses	0.0	4.2
Operating income	163.4	180.9
Consumer | Cost of goods sold
Segment Reporting Information [Line Items]
Transaction and integration expenses		4.0
Flavor Solutions
Segment Reporting Information [Line Items]
Revenues	596.3	534.7
Operating income excluding special charges and transaction and integration expenses	60.1	72.6
Income from unconsolidated operations	0.9	2.5
Less: Special charges	15.9	0.3
Transaction and integration expenses	0.7	14.6
Operating income	43.5	55.4
Flavor Solutions | Cost of goods sold
Segment Reporting Information [Line Items]
Transaction and integration expenses		2.3
Americas
Segment Reporting Information [Line Items]
Revenues	1,022.5	964.8
EMEA
Segment Reporting Information [Line Items]
Revenues	290.5	302.4
Asia/Pacific
Segment Reporting Information [Line Items]
Revenues	$ 209.4	$ 214.3